Ensure availability of sufficient stocks of Essential Medicines by ESI Institutions -reg. (English)

Document text

A E.S.I.C. कर्मचारी राज्य बीमा निगम (श्रम एवं रोजगार मंत्रालय, भारत सरकार) EMPLOYEES' STATE INSURANCE CORPORATION (Ministry of Labour & Employment, Govt. of India) मुख्यालय Headquarters" पंचदीप भवन सीआईजी रोड, नई दिल्ली-110002 PANCHDEEP BHAWAN, C.I.G. MARG, NEW DELHI-110 002 Phone: 011-23604700 Email: dir-gen@esic.nic.in Website: www.esic.nic.in/www.esic.in यू-25/12/Misc./2024-MedV (E-771310) Uडय To Dean/Medical Superintendents PGIMSR's/MC/Hospital Director (Medical) Delhi/Director (Medical) Noida Regional Directors, SMO's ESIC DIMS, ESIS All Sates/UT's Sub: Ensure availability of sufficient stocks of Essential Medicines ESI Institutions -reg. Ref: National List of Essential Medicines-2022 (copy enclosed). Sir/Madam, by As you are aware that Director General of Health Services, Ministry of Health & Family Welfare, Govt. of India has issued National List of Essential Medicines 2022 considered essential for addressing the priority healthcare needs of a population. This list guides the selection of medicine procurement and pricing, ensuring access to crucial medications with aim to promote the judicious use of medications, ensuring their effectiveness and safety. In this context, all Deans/MSs/DIMS of State Directorates are hereby informed to ensure sufficient stocks of Drugs available as per National List of Essential Medicines -2022 for ESI Beneficiaries as per existing purchase policy, duly adhering to GeM/GFR/CVC/ESI/Govt. of India guidelines interalia. This issues with the approval of Competent Authority. This is for your kind information and mandatory compliance. Digitally signवकीय Sanjiv Kochhar Dater04-09-2025 उपचिकित्सा आयुक्त दर संविदा/प्रापण) 16:04:19 National List of Essential Medicines 2022 Table of Contents Sections of Drug Classes Section 1 Medicines used in Anaesthesia............................................................................3 Section 2 Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders.............................................................................6 Section 3 Antiallergics and Medicines used in Anaphylaxis...............................................9 Section 4 Antidotes and Other Substances used in Management of Poisonings/Envenomation .................................................................................11 Section 5 Medicines used in Neurological Disorders.......................................................13 Section 6 Anti-infective Medicines....................................................................................18 Section 7 Anti-cancer agents including Immunosuppressives and Medicines used in Palliative Care....................................................................................................37 Section 8 Medicines affecting Blood.................................................................................45 Section 9 Blood products and Plasma substitutes..............................................................47 Section 10 Cardiovascular Medicines................................................................................49 Section 11 Dermatological Medicines (Topical) ...............................................................54 Section 12 Diagnostic agents .............................................................................................56 Section 13 Dialysis components (Haemodialysis and Peritoneal Dialysis) ......................57 Section 14 Antiseptics and Disinfectants...........................................................................57 Section 15 Diuretics...........................................................................................................58 Section 16 Ear, Nose and Throat Medicines......................................................................59 Section 17 Gastrointestinal Medicines...............................................................................60 Section 18 Hormones, other Endocrine Medicines and Contraceptives............................63 Section 19 Immunologicals................................................................................................67 Section 20 Medicines for Neonatal Care ...........................................................................70 Section 21 Ophthalmological Medicines...........................................................................71 Section 22 Oxytocics and Antioxytocics ...........................................................................73 Section 23 Medicines used in treatment of Psychiatric Disorders.....................................74 Section 24 Medicines acting on the Respiratory tract .......................................................78 Section 25 Solutions correcting Water, Electrolyte disturbances and Acid-base disturbances......................................................................................................80 Section 26 Vitamins and Minerals.....................................................................................81 Section 27 Medicines for COVID 19 management.........................................................82 Alphabetical List of Medicines in NLEM 2022 ...............................................................84 Medicines Added Therapeutic category wise in NLEM 2022 .......................................101 Alphabetical List of Medicines Added to NLEM 2022...................................................113 Medicines Deleted from Therapeutic category wise NLEM 2015................................116 Alphabetical List of Medicines Deleted from NLEM 2015 ............................................127 INDEX 130 Section 1 Medicines used in Anaesthesia 1.1- General Anaesthetics and Oxygen Medicine Level of Healthcare Dosage form(s) and strength(s) 1.1.1 Halothane S,T Liquid for inhalation 1.1.2 Isoflurane S,T Liquid for inhalation 1.1.3 Ketamine P,S,T Injection 10 mg/mL Injection 50 mg/mL 1.1.4 Nitrous oxide P,S,T As licensed for medical purpose 1.1.5 Oxygen* P,S,T As licensed for medical purpose 1.1.6 Propofol P,S,T Injection 10 mg/mL 1.1.7 Sevoflurane S,T Liquid for inhalation 1.1.8 Thiopentone P,S,T Powder for injection 0.5 g Powder for injection 1 g *Oxygen is also listed in Section 27.5 - Medicines for COVID 19 management 1.2-Local Anaesthetics Medicine Level of Healthcare Dosage form(s) and strength(s) 1.2.1 Bupivacaine S,T Injection 0.25 % Injection 0.5 % Injection 0.5 % with 7.5 % glucose 1.2.2 Lignocaine* P,S,T Topical forms 2-5 % Injection 1 % Injection 2 % Injection 5 % with 7.5 % glucose 1.2.3 Lignocaine (A) + Adrenaline (B) P,S,T Injection 1% (A) + 1:200000 (5 mcg/mL) (B) Injection 2% (A) + 1:200000 (5 mcg/mL) (B) 1.3- Preoperative Medication and Sedation for Short Term Procedures Medicine Level of Healthcare Dosage form(s) and strength(s) 1.3.1 Atropine** P,S,T Injection 0.6 mg/mL *Lignocaine formulations are also listed in Section 10.2.5 cardiovascular medicines- Antiarrhythmic medicines **Atropine formulations are also listed in - A. Section 4.2.1 - Antidotes and Other Substances used in Management of Poisonings/Envenomation - Specific B. Section 21.5.1 - Ophthalmological Medicines- Mydriatics Medicine Level of Healthcare Dosage form(s) and strength(s) 1.3.2 Glycopyrrolate S,T Injection 0.2 mg/mL 1.3.3 Midazolam* P,S,T Tablet 7.5 mg Nasal Spray 0.5mg Nasal Spray 1.25 mg Injection 1 mg/mL Injection 5 mg/mL 1.3.4 Morphine** P,S,T Injection 10 mg/mL Injection 15 mg/mL Section 1.4 -Muscle Relaxants and Cholinesterase Inhibitors Medicine Level of Healthcare Dosage form(s) and strength(s) 1.4.1 Atracurium S,T Injection 10 mg/mL 1.4.2 Baclofen S,T Tablet 5 mg Tablet 10 mg Tablet 20 mg *Midazolam formulations are also listed in - A. Section 5.1.7- Medicines used in Neurological Disorders Anticonvulsants/ Antiepileptics B. Section 7.4.12- Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care **Morphine formulations are also listed in - A. Section 2.2.2- Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Opioid Analgesics B. Section 7.4.13 - Anti-cancer agents including immunosuppressives, and medicines used in Palliative Care Medicine Level of Healthcare Dosage form(s) and strength(s) 1.4.3 Neostigmine* S,T Tablet 15 mg Injection 0.5 mg/mL 1.4.4 Succinylcholine S,T Injection 50 mg/mL 1.4.5 Vecuronium S,T Powder for injection 4 mg Powder for injection 10 mg Section 2 Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders 2.1 - Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs Medicine Level of Healthcare Dosage form(s) and strength(s) 2.1.1 Acetylsalicylic acid** P,S,T Tablet 300 mg to 500 mg Effervescent/ Dispersible/ Enteric coated Tablet 300 mg to 500 mg *Neostigmine formulations are also listed in Section 4.2.8 - Antidotes and Other substances used in Management of poisoning/Envenomation - Specific **Acetylsalicylic acid formulations are also listed in - A. Section 5.2.1 - Medicines used in Neurological Disorders Antimigraine medicines B. Section 10.5.1 - Cardiovascular medicines -Antithrombotic Medicines (Cardiovascular/ Cerebrovascular) - Antiplatelet and Antithrombotic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 2.1.2 Diclofenac P,S,T Tablet 50 mg Injection 25 mg/mL 2.1.3 Ibuprofen* P,S,T Tablet 200 mg Tablet 400 mg Oral liquid 100 mg/5 mL (p) 2.1.4 Mefenamic acid P,S,T Tablet 250 mg Oral liquid 100 mg/5 mL (p) 2.1.5 Paracetamol** P,S,T Tablet 500 mg Tablet 650 mg Oral liquid 120 mg/5 mL (p) Oral Liquid 125 mg/5 mL (p) Oral Liquid 250 mg/5 mL (p) Injection 150 mg/ mL Suppository 80 mg Suppository 170 mg 2.2-Opioid Analgesics Medicine Level of Healthcare Dosage form(s) and strength(s) 2.2.1 Fentanyl S,T Injection 50 mcg/mL *Ibuprofen formulations are also listed in Section 5.2.2 - Medicines used in Neurological Disorders-Antimigraine Medicines ** Paracetamol formulations are also listed in - A. Section 5.2.3 - Medicines used in Neurological Disorders-Antimigraine Medicines B. Section 27.4 - Medicines for COVID 19 Management Medicine Level of Healthcare Dosage form(s) and strength(s) 2.2.2 Morphine* P,S,T Tablet 10 mg Injection 10 mg/mL Injection 15 mg/mL 2.2.3 Tramadol** S,T Capsule 50 mg Capsule 100 mg Injection 50 mg/mL 2.3-Medicines used to treat Gout Medicine Level of Healthcare Dosage form(s) and strength(s) 2.3.1 Allopurinol*** P,S,T Tablet 100 mg Tablet 300 mg 2.3.2 Colchicine P,S,T Tablet 0.5 mg *Morphine formulations are also listed in - A. Section 1.3.4 - Medicines used in Anaesthesia - Preoperative medication and sedation for short term procedures B. Section 7.4.13 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care ** Tramadol formulations are also listed in Section 7.4.15 - Tramadol formulations are also listed in Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care *** Allopurinol formulations are also listed in Section 7.4.1 - Allopurinol formulations are also listed in Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care 2.4-Disease Modifying Agents used in Rheumatoid Disorders Medicine Level of Healthcare Dosage form(s) and strength(s) 2.4.1 Azathioprine* S,T Tablet 25 mg (p) Tablet 50 mg 2.4.2 Hydroxychloroquine P,S,T Tablet 200 mg Tablet 400 mg 2.4.3 Methotrexate** P,S,T Tablet 2.5 mg Tablet 5 mg Tablet 10 mg 2.4.4 Sulfasalazine S,T Tablet 500 mg Section 3 Antiallergics and Medicines used in Anaphylaxis Medicine Level of Healthcare Dosage form(s) and strength(s) 3.1 Adrenaline P,S,T Injection 1 mg/mL 3.2 Cetirizine P,S,T Tablet 10 mg Oral liquid 5 mg/5 mL (p) * Azathioprine formulations are also listed in Section 7.3.1 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care ** Methotrexate formulations are also listed in Section 7.1.30 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Medicine Level of Healthcare Dosage form(s) and strength(s) 3.3 Dexamethasone* P,S,T Tablet 0.5 mg Tablet 2 mg Tablet 4 mg Oral liquid 0.5 mg/5 mL (p) Injection 4 mg/mL 3.4 Hydrocortisone** P,S,T Tablet 5 mg Tablet 10 mg Powder for Injection 100 mg Powder for Injection 200 mg 3.5 Pheniramine P,S,T Injection 22.75 mg/mL 3.6 Prednisolone*** P,S,T Tablet 5 mg Tablet 10 mg Tablet 20 mg Oral liquid 5 mg/5 mL (p) Oral liquid 15 mg/5 mL (p) *Dexamethasone formulations are also listed in - A. Section 7.4.3 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care B. Section 18.1.1 - Hormones, other Endocrine Medicines and Contraceptives - Adrenal Hormones and Synthetic Substitutes C. Section 27.1 - Medicines for COVID 19 Management ** Hydrocortisone formulations are also listed in Section 18.1.3 - Hormones, other Endocrine Medicines and Contraceptives- Adrenal Hormones and Synthetic Substitutes ***Prednisolone formulations are also listed in - A. Section 7.2.4 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Hormones and Anti-Hormones used in cancer therapy B. Section 18.1.5 - Hormones, other Endocrine Medicines and Contraceptives -Adrenal Hormones and Synthetic Substitutes C. Section 21.2.1 - Ophthalmological Medicines- Anti-inflammatory Medicine Section 4 Antidotes and Other Substances used in Management of Poisonings/Envenomation 4.1-Nonspecific Medicine Level of Healthcare Dosage form(s) and strength(s) 4.1.1 Activated Charcoal P,S,T Powder (as licensed) 4.2 Specific Medicine Level of Healthcare Dosage form(s) and strength(s) 4.2.1 Atropine* P,S,T Injection 0.6 mg/mL 4.2.2 Calcium gluconate** P,S,T Injection 100 mg/mL 4.2.3 D- Penicillamine P,S,T Capsule 150 mg (p) Capsule 250 mg 4.2.4 Desferrioxamine S,T Powder for injection 500 mg 4.2.5 Methylthioninium chloride (Methylene blue) S,T Injection 10 mg/mL *Atropine formulations are also listed in - A. Section 1.3.1 - Medicines used in Anaesthesia -Preoperative Medication and Sedation for short term procedures B. Section 21.5.1 - Ophthalmological Medicines- Mydriatics ** Calcium gluconate formulations are also listed in Section 26.3 - Vitamins and minerals Medicine Level of Healthcare Dosage form(s) and strength(s) 4.2.6 N-acetylcysteine P,S,T Sachet 200 mg Injection 200 mg/mL 4.2.7 Naloxone P,S,T Injection 0.4 mg/mL 4.2.8 Neostigmine* P,S,T Injection 0.5 mg/mL 4.2.9 Pralidoxime chloride (2-PAM) P,S,T Injection 25 mg/mL 4.2.10 Snake venom antiserum** P,S,T Soluble/ liquid polyvalent - As licensed Lyophilized polyvalent - As licensed 4.2.11 Sodium nitrite S,T Injection 30 mg/mL 4.2.12 Sodium thiosulphate S,T Injection 250 mg/mL * Neostigmine formulations are also listed in Section 1.4.3 - Medicines used in Anaesthesia - Muscle relaxants and cholinesterase inhibitors ** Snake Venom antiserum is also listed in Section 19.2.7. - Immunologicals - Sera and immunoglobulins (Liquid/ Lyophilized) Section 5 Medicines used in Neurological Disorders Section 5.1-Anticonvulsants/ Antiepileptics Medicine Level of Healthcare Dosage form(s) and strength(s) 5.1.1 Carbamazepine* P,S,T Tablet 100 mg Tablet 200 mg Tablet 400 mg Modified Release - Tablet 200 mg Tablet 400 mg Oral liquid 100 mg/5 mL (p) 5.1.2 Clobazam S,T Tablet 5 mg Tablet 10 mg 5.1.3 Diazepam** P,S,T Oral liquid 2 mg/5 mL (p) Injection 5 mg/mL Suppository 5 mg 5.1.4 Levetiracetam S,T Tablet 250 mg Tablet 500 mg Tablet 750 mg Modified Release Tablet 750 mg Oral liquid 100 mg/mL (p) Injection 100 mg/mL 5.1.5 Lorazepam P,S,T Tablet 1 mg Tablet 2 mg Injection 2 mg/mL Injection 4 mg/mL *Carbamazepine formulations are also listed in Section 23.2.2.3 Medicines used in treatment of Psychiatric disorder - Medicines used in Bipolar disorders ** Diazepam formulations are also listed in Section 7.4.4 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care Medicine Level of Healthcare Dosage form(s) and strength(s) 5.1.6 Magnesium sulphate S,T Injection 500 mg/mL 5.1.7 Midazolam* P,S,T Tablet 7.5 mg Tablet 15 mg Nasal Spray 0.5 mg/actuation Nasal Spray 1.25 mg/actuation Injection 1 mg/mL Injection 5 mg/mL 5.1.8 Phenobarbitone P,S,T Tablet 30 mg Tablet 60 mg Oral liquid 20 mg/5 mL (p) S,T Injection 200 mg/mL 5.1.9 Phenytoin P,S,T Tablet 50 mg Tablet 100 mg Tablet 300 mg Modified Release Tablet 300 mg Oral liquid 30 mg/5 mL (p) Oral liquid 125 mg/5 mL (p) Injection 25 mg/mL Injection 50 mg/mL *Midazolam formulations are also listed in - A. Section 1.3.3 - Medicines used in Anaesthesia - Preoperative Medication and Sedation for short term procedures B. Section 7.4.12 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care Medicine Level of Healthcare Dosage form(s) and strength(s) 5.1.10 Sodium Valproate* P,S,T Tablet 200 mg Tablet 300 mg Tablet 500 mg Modified Release - Tablet 300 mg Tablet 500 mg Oral liquid 200 mg/5 mL (p) S,T Injection 100 mg/mL Section 5.2- Antimigraine Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 5.2.1 Acetylsalicylic acid** P,S,T Tablet 300 mg to 500 mg Effervescent/ Dispersible/ Enteric coated Tablet 300 mg to 500 mg *Sodium Valproate formulations are also listed in- Section 23.2.2.2 - Medicines used in treatment of Psychiatric Disorders -Medicines used in Bipolar disorders- Medicines used in mood disorders **Acetylsalicyclic acid formulations are also listed in - A. Section 2.1.1 - Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs B. Section 10.5.1 - Cardiovascular medicines- Antiplatelet and Antithrombotic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 5.2.2 Ibuprofen* P,S,T Tablet 200 mg Tablet 400 mg Oral liquid 100 mg/5 mL (p) 5.2.3 Paracetamol** P,S,T Tablet 500 mg Tablet 650 mg Oral liquid 120 mg/5mL (p) Oral Liquid 125 mg/5mL (p) Oral Liquid 250 mg/5mL (p) 5.2.4 Sumatriptan P,S,T Tablet 25 mg Tablet 50 mg Section 5.2.1 - For Prophylaxis 5.2.1.1 Amitriptyline*** P,S,T Tablet 10 mg Tablet 25 mg Tablet 75 mg *Ibuprofen formulations are also listed in Section 2.1.3 - Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs **Paracetamol formulations are also listed in - A. Section 2.1.5 - Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Non-opioid analgesics, antipyretics and nonsteroidal anti- inflammatory medicines B. Section 27.4 - Medicines for COVID 19 management *** Amitriptyline formulations are also listed in - A. Section 7.4.2 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care- B. Section 23.2.1.1 - Medicines used in treatment of Psychiatric Disorders -Medicines used in mood disorders- Medicines used in depressive disorders Medicine Level of Healthcare Dosage form(s) and strength(s) 5.2.1.2 Flunarizine P,S,T Tablet 5 mg Tablet 10 mg 5.2.1.3 Propranolol P,S,T Tablet 10 mg Tablet 20 mg Tablet 40 mg Section 5.3- Antiparkinsonism Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 5.3.1 Levodopa (A) + Carbidopa (B) P,S,T Tablet 100 mg (A) + 10 mg (B) Tablet 100 mg (A) + 25 mg (B) Tablet 250 mg (A) + 25 mg (B) Modified Release - Tablet 100 mg (A) + 25 mg (B) Tablet 200 mg (A) + 50 mg (B) 5.3.2 Trihexyphenidyl P,S,T Tablet 2 mg Section 5.4-Medicines used in Dementia Medicine Level of Healthcare Dosage form(s) and strength(s) 5.4.1 Donepezil S,T Tablet 5 mg Tablet 10 mg Section 6 Anti-infective Medicines 6.1-Anthelminthics 6.1.1- Intestinal Anthelminthics Medicine Level of Healthcare Dosage form(s) and strength(s) 6.1.1.1 Albendazole* P,S,T Tablet 400 mg Chewable Tablet 400 mg Oral liquid 200 mg/5 mL (p) 6.1.1.2 Mebendazole P,S,T Tablet 100 mg Oral liquid 100 mg/5 mL (p) 6.1.2 Antifilarial Medicine Level of Healthcare Dosage form(s) and strength(s) 6.1.2.1 Albendazole* P,S,T Tablet 400 mg Chewable Tablet 400 mg Oral liquid 200 mg/5 mL (p) 6.1.2.2 Diethylcarbamazine (DEC) P,S,T Tablet 50 mg Tablet 100 mg Oral liquid 120 mg/5 mL (p) * Albendazole formulations are also listed Section 6.1.1.1 - in Anti-infective Medicines- Antifilarial Medicine Level of Healthcare Dosage form(s) and strength(s) 6.1.2.3 Ivermectin P,S,T Tablet 6 mg Tablet 12 mg 6.1.3 - Anti-schistosomal and Anti-trematodal Medicine Medicine Level of Healthcare Dosage form(s) and strength(s) 6.1.3.1 Praziquantel S,T Tablet 600 mg 6.2-Antibacterials 6.2.1 Beta-lactam Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 6.2.1.1 Amoxicillin P,S,T Capsule 250 mg Capsule 500 mg Oral liquid 125 mg/5 mL (p) Oral liquid 250 mg/5 mL (p) Powder for Injection 250 mg Powder for Injection 500 mg Powder for injection 1000 mg 6.2.1.2 Amoxicillin (A) + Clavulanic acid (B) P,S,T Tablet 500 mg (A) + 125 mg (B) Oral liquid 200 mg (A) + 28.5 mg (B)/5 mL (p) Dry Syrup 125 mg (A) + 31.25 (B)/ 5 mL (p) S,T Powder for Injection 500 mg (A) + 100 mg (B) Powder for Injection 1 g (A) + 200 mg (B) Medicine Level of Healthcare Dosage form(s) and strength(s) 6.2.1.3 Ampicillin P,S,T Powder for Injection 500 mg Powder for Injection 1000 mg 6.2.1.4 Benzathine benzylpenicillin P,S,T Powder for Injection 6 lac units Powder for Injection 12 lac units Powder for injection 24 lac units 6.2.1.5 Benzylpenicillin P,S,T Powder for injection 5 lac units Powder for injection 10 lac units 6.2.1.6 Cefadroxil P,S,T Tablet 500 mg Tablet 100 mg Oral liquid 125 mg/5 mL (p) 6.2.1.7 Cefazolin P,S,T Powder for Injection 500 mg Powder for Injection 1000 mg 6.2.1.8 Cefixime S,T Tablet 200 mg Tablet 400 mg Oral liquid 50 mg/5 mL (p) Oral liquid 100 mg/5 mL (p) 6.2.1.9 Cefotaxime* S,T Powder for Injection 250 mg Powder for Injection 500 mg Powder for Injection 1000 mg *Cefotaxime formulations are also listed in Section 6.7.5.2 - Anti-infective Medicines- Antiviral Medicines- Medicines for treating Opportunistic Infections in People living with HIV Medicine Level of Healthcare Dosage form(s) and strength(s) 6.2.1.10 Ceftazidime S,T Powder for Injection 250 mg Powder for Injection 1000 mg 6.2.1.11 Ceftriaxone S,T Powder for Injection 250 mg Powder for Injection 500 mg Powder for Injection 1000 mg Powder for Injection 2000 mg 6.2.1.12 Cloxacillin P,S,T Capsule 250 mg Capsule 500 mg Oral Liquid 125 mg/5 mL (p) Powder for Injection 250 mg 6.2.1.13 Piperacillin (A) + Tazobactam (B) T Powder for Injection 1000 mg (A) + 125 mg (B) Powder for Injection 2000 mg (A) + 250 mg (B) Powder for Injection 4000 mg (A) + 500 mg (B) 6.2.1.14 Meropenem T Powder for Injection 500 mg (as trihydrate) Powder for Injection 1000 mg (as trihydrate) 6.2.2 - Other Antibacterials Medicine Level of Healthcare Dosage form(s) and strength(s) 6.2.2.1 Azithromycin* P,S,T Tablet 250 mg Tablet 500 mg Oral liquid 200 mg/5 mL (p) Powder for Injection 500 mg 6.2.2.2 Cefuroxime P,S,T Tablet 500 mg Oral liquid 125 mg/ 5 mL (p) Injection 1500 mg *Azithromycin formulations are also listed in Section 6.7.6.1 Anti-infective Medicines - Medicines used in the management of HIV- Additional Medicines for Syndromic Management of Sexually Transmitted Infections Medicine Level of Healthcare Dosage form(s) and strength(s) 6.2.2.3 Ciprofloxacin* P,S,T Tablet 250 mg Tablet 500 mg Oral liquid 250 mg/ 5 mL (p) Injection 200 mg/ 100 mL 6.2.2.4 Clarithromycin** S,T Tablet 250 mg Tablet 500 mg Oral liquid 125 mg/5 mL (p) 6.2.2.5 Clindamycin*** P,S,T Capsule 150 mg Capsule 300 mg Injection 150 mg /mL 6.2.2.6 Co-trimoxazole [Sulphamethoxazole (A) + Trimethoprim (B)]**** P,S,T Tablet 400 mg (A) + 80 mg (B) Tablet 800 mg (A) + 160 mg (B) Oral liquid 200 mg (A) + 40 mg (B)/5 mL (p) * Ciprofloxacin formulations are also listed in - A. Section 16.2 - Ear, Nose and ThroatMedicines, B. Section 21.1.2 - Ophthalmological Medicines- Anti-infective Medicines, ** Clarithromycin formulations are also listed in Section 6.4.3 - Anti-infective medicines- Anti-tuberculosis Medicines ***Clindamycin formulations are also listed in - A. Section 6.7.5.3 - Anti-infective Medicines- Antiviral Medicines- Medicines for treating Opportunistic Infections in People living with HIV B. Section 6.9.3.1 - Anti-infective Medicines- Drugs for amoebiasis and other parasitic infections -Antipneumocystosis and antitoxoplasmosis medicines C. Section 6.10.1.5 - Anti-infective Medicines- Antimalarial medicines- For curative treatment **** Co-trimoxazole formulations are also listed in Section 6.9.3.2 - Anti-infective Medicines- Medicines for amoebiasis and other parasitic infections -Antipneumocystosis and antitoxoplasmosis medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 6.2.2.7 Doxycycline* P,S,T Capsule 100 mg Dry Syrup 50 mg/5 mL (p) Power for Injection 100 mg 6.2.2.8 Gentamicin P,S,T Injection 10 mg/mL Injection 40 mg/mL 6.2.2.9 Metronidazole** P,S,T Tablet 200 mg Tablet 400 mg Oral liquid 200 mg/5 mL (p) Injection 500 mg/100 mL 6.2.2.10 Nitrofurantoin P,S,T Tablet 100 mg Oral liquid 25 mg/5 mL (p) 6.2.2.11 Phenoxymethyl penicillin P,S,T Tablet 250 mg 6.2.2.12 Procaine Benzylpenicillin P,S,T Powder for injection 1000 mg (=1 million IU) 6.2.2.13 Vancomycin S,T Capsule 125 mg Capsule 250 mg Powder for Injection 250 mg Powder for Injection 500 mg Powder for Injection 1000 mg *Doxycycline formulations are also listed in Section 6.10.2.1 - Anti-infective Medicines- Antimalarial medicines- For prophylaxis **Metronidazole formulations are also listed in Section 6.9.1.1 - Anti-infective Medicines - Antiprotozoal Medicines - Medicines for amoebiasis and other parasitic infections 6.3 - Antileprosy Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 6.3.1 Clofazimine* P,S,T Capsule 50 mg Capsule 100 mg 6.3.2 Dapsone P,S,T Tablet 50 mg Tablet 100 mg 6.3.3 Rifampicin** P,S,T Capsule 150 mg Capsule 300 mg 6.4-Antituberculosis Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 6.4.1 Amikacin S,T Injection 100 mg/mL Injection 250 mg/mL Injection 500 mg/mL 6.4.2 Bedaquiline T Tablet 100 mg 6.4.3 Clarithromycin*** S,T Tablet 250 mg Tablet 500 mg Tablet 750 mg *Clofazimine formulations are also listed Section 6.4.5 - Anti-infective Medicines - Anti-tuberculosis medicines **Rifampicin formulations are also listed in Section 6.4.15 - Anti-infective Medicines - Anti-tubercular medicine ***Clarithromycin formulations are also listed in Section 6.2.2.4 - Anti-infective Medicines- Antibacterials -Other Antibacterials Medicine Level of Healthcare Dosage form(s) and strength(s) 6.4.4 Clofazimine* S,T Capsule 50 mg Capsule 100 mg 6.4.5 Cycloserine S,T Capsule 125 mg Capsule 250 mg 6.4.6 Delamanid T Tablet 50 mg 6.4.7 Ethambutol P,S,T Tablet 200 mg Tablet 400 mg Tablet 600 mg Tablet 800 mg 6.4.8 Ethionamide S,T Tablet 125 mg Tablet 250 mg 6.4.9 Isoniazid P,S,T Tablet 100 mg Tablet 300 mg Oral Liquid 50 mg/5 mL (p) 6.4.10 Levofloxacin P,S,T Tablet 250 mg Tablet 500 mg Tablet 750 mg 6.4.11 Linezolid P,S,T Tablet 300 mg Tablet 600 mg 6.4.12 Moxifloxacin P,S,T Tablet 400 mg *Clofazimine formulations are also listed in Section 6.3.1 - Anti-infective Medicines - Antileprosy medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 6.4.13 Para- aminosalicylic acid S,T Granules (As licensed) 6.4.14 Pyrazinamide P,S,T Tablet 500 mg Tablet 750 mg Tablet 1000 mg Tablet 1500 mg Oral liquid 250 mg/5 mL (p) 6.4.15 Rifampicin* P,S,T Capsule 150 mg Capsule 300 mg Capsule 450 mg Capsule 600 mg Oral liquid 100 mg/ 5 mL (p) 6.4.16 Streptomycin P,S,T Powder for Injection 750 mg Powder for Injection 1000 mg 6.5 - Antifungal Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 6.5.1 Amphotericin B** S,T a) Amphotericin B (conventional) - Injection 50 mg/vial b) Lipid Amphotericin B - Injection 50 mg/vial c) Liposomal Amphotericin B - Injection 50 mg/vial *Rifampicin formulations are also listed in Section 6.3.3 - Anti-infective Medicines- Antileprosy medicines **Amphotericin B formulations are also listed Section 6.9.2.1 - Anti-infective Medicines Antileishmaniasis medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 6.5.2 Clotrimazole* P,S,T Pessary 100 mg 6.5.3 Fluconazole P,S,T Tablet 50 mg Tablet 100 mg Tablet 150 mg Tablet 200 mg Tablet 400 mg Oral liquid 50 mg/ 5 mL (p) S,T Injection 200 mg / 100 mL 6.5.4 Griseofulvin P,S,T Tablet 125 mg Tablet 250 mg Tablet 375 mg 6.5.5 Itraconazole S,T Capsule 100 mg Capsule 200 mg Oral liquid 10 mg/mL 6.5.6 Mupirocin P,S,T Ointment 2% 6.5.7 Nystatin S,T Pessary 1 Lac IU Oral Liquid 1 Lac IU/mL (p) 6.5.8 Terbinafine P,S,T Cream 1% *Clotrimazole formulations are also listed in - A. Section 6.7.5.4 - Anti-infective Medicines Antiviral medicines- Medicines for treating Opportunistic Infections in People living with HIV B. Section 11.1.1 - Dermatological Medicines (Topical)- Antifungal medicines C. Section 16.3 - Ear, Nose and Throat Medicines 6.6 - Antiviral Medicines 6.6.1 - Antiherpes Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 6.6.1.1 Acyclovir* P,S,T Tablet 200 mg Tablet 400 mg Tablet 800 mg Powder for Injection 250 mg Powder for Injection 500 mg Oral liquid 400 mg/5 mL (p) 6.6.2 - Anti-cytomegalovirus (CMV) medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 6.6.2.1 Valganciclovir** S, T Tablet 450 mg Powder for oral solution 50 mg/mL 6.7- Medicines used in the Management of HIV 6.7.1 Nucleoside Reverse Transcriptase Inhibitors Medicine Level of Healthcare Dosage form(s) and strength(s) 6.7.1.1 Abacavir S,T Tablet 60 mg (p) Tablet 300 mg *Acyclovir formulations are also listed in - A. Section 6.7.5.1 - Anti-infective Medicines -Medicines used in the management of HIV - Medicines for treating Opportunistic Infections in People living with HIV B. Section 21.1.1 - Ophthalmological Medicines- Anti-infective medicine **Valganciclovir formulations are also listed in Section 6.7.5.5 - Anti-infective Medicines- Antiviral medicines -Medicines for treating Opportunistic Infections in People living with HIV Medicine Level of Healthcare Dosage form(s) and strength(s) 6.7.1.2 Abacavir (A) + Lamivudine (B) S,T Tablet 60 mg (A) + 30 mg (B) (p) Tablet 600 mg (A) + 300 mg (B) 6.7.1.3 Lamivudine S,T Tablet 100 mg Tablet 150 mg 6.7.1.4 Tenofovir Disproxil Fumarate (TDF)* S,T Tablet 300 mg 6.7.1.5 Tenofovir Disproxil Fumarate (A) + Lamivudine (B) S,T Tablet 300 mg (A) + 300 mg (B) 6.7.1.6 Tenofovir Disproxil Fumarate (A) + Lamivudine (B) + Dolutegravir (C) P,S,T Tablet 300 mg (A) + 300 mg (B) + 50 mg (C) 6.7.1.7 Tenofovir Disproxil Fumarate (A) + Lamivudine (B) + Efavirenz (C) S,T Tablet 300 mg (A) + 300 mg (B) + 600 mg (C) 6.7.1.8 Zidovudine S,T Tablet 300 mg Oral liquid 50 mg/5 mL (p) 6.7.1.9 Zidovudine (A) + Lamivudine (B) S,T Tablet 60 mg (A) + 30 mg (B) (p) Tablet 300 mg (A) + 150 mg (B) * Tenofovir Disproxil Fumarate formulations are also listed in Section 6.8.6 - Anti-infective Medicines Medicines used in Hepatitis B and Hepatitis C Medicine Level of Healthcare Dosage form(s) and strength(s) 6.7.1.10 Zidovudine (A) + Lamivudine (B) + Nevirapine (C) S,T Tablet 60 mg (A) + 30 mg (B) + 50 mg (C) (p) Tablet 300 mg (A) + 150 mg (B) + 200 mg (C) 6.7.2 Non-nucleoside Reverse Transcriptase Inhibitors Medicine Level of Healthcare Dosage form(s) and strength(s) 6.7.2.1 Efavirenz S,T Tablet 200 mg (p) Tablet 600 mg 6.7.2.2 Nevirapine P,S,T Tablet 200 mg Dispersible Tablet 50 mg (p) Oral liquid 50 mg/ 5 mL (p) 6.7.3 Integrase Inhibitors Medicine Level of Healthcare Dosage form(s) and strength(s) 6.7.3.1 Dolutegravir S,T Tablet 50 mg 6.7.3.2 Raltegravir S,T Tablet 400 mg 6.7.4 Protease Inhibitors Medicine Level of Healthcare Dosage form(s) and strength(s) 6.7.4.1 Atazanavir (A) + Ritonavir (B) S,T Tablet 300 mg (A) + Tablet 100 mg (B) Medicine Level of Healthcare Dosage form(s) and strength(s) 6.7.4.2 Darunavir S,T Tablet 600 mg 6.7.4.3 Darunavir (A) + Ritonavir (B) S,T Tablet 600 mg (A) + Tablet 100 mg (B) 6.7.4.4 Lopinavir (A) + Ritonavir (B) S,T Tablet 100 mg (A) + 25 mg (B) Tablet 200 mg (A) + 50 mg (B) Oral Liquid 80 mg (A) + 20 mg (B) /mL (p) Capsule/ Sachet (containing pellets/granules) 40 mg (A) + 10 mg (B) (p) 6.7.4.5 Ritonavir S,T Tablet 100 mg 6.7.5 Medicines for treating Opportunistic Infections in People living with HIV Medicine Level of Healthcare Dosage form(s) and strength(s) 6.7.5.1 Acyclovir* P,S,T Injection 250 mg 6.7.5.2 Cefotaxime** P,S,T Injection 1000 mg 6.7.5.3 Clindamycin*** P,S,T Tablet 300 mg *Acyclovir formulations are also listed in - A. Section 6.6.1.1 - Anti-infective Medicines -Antiviral medicines -Anti-herpes medicines B. Section 21.1.1 - Ophthalmological Medicines- Anti-infective Medicine ** Cefotaxime formulations are also listed in Section 6.2.1.9 - Anti-infective Medicines - Antibacterials- Beta-Lactam medicines ***Clindamycin formulations are also listed in -A. Section 6.2.2.5 - Anti-infective Medicines - Antibacterials -Other antibacterials B. Section 6.9.3.1 - Anti-infective Medicines - Medicines for amoebiasis and other parasitic infections - Antipneumocystosis and antitoxoplasmosis medicines C. Section 6.10.1.5 - Anti-infective Medicines - Antimalarial medicines- For curative treatment Medicine Level of Healthcare Dosage form(s) and strength(s) 6.7.5.4 Clotrimazole* P,S,T Ointment 1 % 6.7.5.5 Valganciclovir** S,T Tablet/Capsule 450 mg 6.7.6 Additional Medicines for Syndromic Management of Sexually Transmitted Infections Medicine Level of Healthcare Dosage form(s) and strength(s) 6.7.6.1 Azithromycin*** P,S,T Tablet 1000 mg Section 6.8 -Medicines used in Hepatitis B and Hepatitis C Medicine Level of Healthcare Dosage form(s) and strength(s) 6.8.1 Daclatasvir S,T Tablet 30 mg Tablet 60 mg 6.8.2 Entecavir S,T Tablet 0.5 mg Tablet 1 mg Oral liquid 0.05 mg/mL (p) *Clotrimazole formulations are also listed in - A. Section 6.5.2 - Anti-infective Medicines -Antifungal medicines B. Section 11.1.1 - Dermatological Medicines (Topical)- Antifungal medicines C. Section 16.3 - Ear, Nose and Throat Medicines **Valganciclovir formulations are also listed in Section 6.6.2.1 - Anti-infective Medicines - Antiviral medicines -Anti Cytomegalovirus (CMV) medicines ***Azithromycin formulations are also listed in Section 6.2.2.1 - Anti-infective Medicines - Other antibacterials Medicine Level of Healthcare Dosage form(s) and strength(s) 6.8.3 Ribavirin S,T Capsule 200 mg 6.8.4 Sofosbuvir S,T Tablet 400 mg 6.8.5 Tenofovir Alafenamide Fumarate (TAF) S,T Tablet 25 mg 6.8.6 Tenofovir Disproxil Fumarate (TDF)* S,T Tablet 300 mg Section 6.9 -Antiprotozoal Medicines 6.9.1 - Medicines for Amoebiasis and other Parasitic Infections Medicine Level of Healthcare Dosage form(s) and strength(s) 6.9.1.1 Metronidazole** P,S,T Tablet 200 mg Tablet 400 mg Injection 500 mg/100 mL Oral liquid 200 mg/5 mL (p) * Tenofovir Disproxil Fumarate formulations are also listed in Section 6.7.1.4 - Anti-infective Medicines Medicines used in the management of HIV- Nucleoside reverse transcriptase inhibitors ** Metronidazole formulations are also listed in Section 6.2.2.9 - Anti-infective Medicines - Antibacterials Beta-lactam medicines - Other antibacterials 6.9.2 - Antileishmaniasis Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 6.9.2.1 Amphotericin B* S,T a) Amphotericin B (conventional)- Injection 50 mg b) Lipid Amphotericin B- Injection 50 mg c) Liposomal Amphotericin B- Injection 50 mg 6.9.2.2 Miltefosine P,S,T Capsule 50 mg 6.9.2.3 Paromomycin P,S,T Injection 375 mg/mL 6.9.3 - Antipneumocystosis and Antitoxoplasmosis Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 6.9.3.1 Clindamycin** P,S,T Capsule 150 mg Capsule 300 mg *Amphotericin B formulations are also listed in Section 6.5.1 - Anti-infective Medicines- Antifungal medicines **Clindamycin formulations are also listed in - A. Section 6.2.2.5 - Anti-infective Medicines - Antibacterials -Other antibacterials B. Section 6.7.5.3 - Anti-infective Medicines - Antiviral medicines- Medicines for treating Opportunistic Infections in People living with HIV C. Section 6.10.1.5 - Anti-infective Medicines- Antimalarial Medicines - For curative treatment Medicine Level of Healthcare Dosage form(s) and strength(s) 6.9.3.2 Co-trimoxazole* [Sulphamethoxazole (A) + Trimethoprim (B)] P,S,T Tablet 400 mg (A) + 80 mg (B) Tablet 800 mg (A) + 160 mg (B) Oral liquid 200 mg (A) + 40 mg (B)/5 mL (p) 6.10-Antimalarial Medicines 6.10.1 - For curative treatment Medicine Level of Healthcare Dosage form(s) and strength(s) 6.10.1.1 Artemether (A) + Lumefantrine (B) P,S,T Tablet 20 mg (A) + 120 mg (B) Tablet 40 mg (A) + 240 mg (B) Tablet 80 mg (A) + 480 mg (B) 6.10.1.2 Artesunate P,S,T Powder for Injection 60 mg Powder for Injection 120 mg 6.10.1.3 Artesunate (A) + Sulphadoxine - Pyrimethamine (B) P,S,T Combi pack (A+B) 1 Tablet 25 mg (A) + 1 Tablet (250 mg + 12.5 mg) (B) 1 Tablet 50 mg (A) + 1 Tablet (500 mg + 25 mg) (B) 1 Tablet 100 mg (A) + 1 Tablet (750 mg + 37.5 mg) (B) 1 Tablet 150 mg (A) + 2 Tablet (500 mg + 25 mg) (B) 1 Tablet 200 mg (A) + 2 Tablet (750 mg + 37.5 mg) (B) *Co-trimoxazole formulations are also listed in Section 6.2.2.6 - Anti-infective Medicines- Antibacterials - Other antibacterials Medicine Level of Healthcare Dosage form(s) and strength(s) 6.10.1.4 Chloroquine P,S,T Tablet 150 mg Oral liquid 50 mg/5 mL 6.10.1.5 Clindamycin* P,S,T Capsule 150 mg Capsule 300 mg 6.10.1.6 Primaquine P,S,T Tablet 2.5 mg Tablet 7.5 mg Tablet 15 mg 6.10.1.7 Quinine P,S,T Tablet 300 mg Injection 300 mg/mL 6.10.2 - For prophylaxis Medicine Level of Healthcare Dosage form(s) and strength(s) 6.10.2.1 Doxycycline**# P,S,T Capsule 100 mg Oral liquid 50 mg/ 5mL #for prophylaxis of P. vivax 6.10.2.2 Mefloquine# T Tablet 250 mg #Only for use as chemoprophylaxis for long term travellers like military and travel troops, travelling from low endemic to high endemic area. * Clindamycin formulations are also listed in - A. Section 6.2.2.5 - Anti-infective Medicines - Antibacterials -Other antibacterials B. Section 6.7.5.3 - Anti-infective Medicines - Antiviral medicines- Medicines for treating Opportunistic Infections in People living with HIV C. Section 6.9.3.1 - Anti-infective Medicines - Antipneumocystosis and antitoxoplasmosis medicines ** Doxycycline formulations are also listed in Section 6.2.2.7 - Anti-infective Medicines- Antibacterials - Other antibacterials Section 7 Anti-cancer agents including Immunosuppressives and Medicines used in Palliative Care 7.1 - Antineoplastic medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 7.1.1 5-Fluorouracil T Injection 250 mg/ 5 mL 7.1.2 6-Mercaptopurine T Tablet 50 mg 7.1.3 Actinomycin D T Powder for Injection 0.5 mg 7.1.4 All-trans retinoic acid T Capsule 10 mg 7.1.5 Arsenic trioxide T Injection 1mg/ mL 7.1.6 Bendamustine hydrochloride T Injection 25 mg/ vial Injection 100 mg/vial 7.1.7 Bleomycin T Powder for Injection 15 units 7.1.8 Bortezomib T Powder for Injection 2 mg 7.1.9 Calcium folinate T Tablet 15 mg Injection 3 mg/mL 7.1.10 Capecitabine T Tablet 500 mg Medicine Level of Healthcare Dosage form(s) and strength(s) 7.1.11 Carboplatin T Injection 10 mg/mL 7.1.12 Chlorambucil T Tablet 2 mg Tablet 5 mg 7.1.13 Cisplatin T Injection 1mg/mL 7.1.14 Cyclophosphamide T Tablet 50 mg Powder for Injection 500 mg 7.1.15 Cytosine arabinoside T Injection 100 mg/vial Injection 500 mg/vial Injection 1000 mg/vial 7.1.16 Dacarbazine T Powder for Injection 200 mg Powder for Injection 500 mg 7.1.17 Daunorubicin T Injection 5 mg/mL 7.1.18 Docetaxel T Powder for Injection 20 mg Powder for Injection 80 mg 7.1.19 Doxorubicin T Injection 2 mg/mL 7.1.20 Etoposide T Capsule 50 mg Injection 20 mg/mL 7.1.21 Gefitinib T Tablet 250 mg Medicine Level of Healthcare Dosage form(s) and strength(s) 7.1.22 Gemcitabine T Powder for Injection 200 mg Powder for Injection 1000 mg 7.1.23 Hydroxyurea* T Capsule 500 mg 7.1.24 Ifosfamide T Powder for Injection 1000 mg Powder for Injection 2000 mg 7.1.25 Imatinib T Tablet 100 mg Tablet 400 mg 7.1.26 Irinotecan HCl trihydrate T Solution for injection 20 mg/ mL 7.1.27 L-Asparaginase T Powder for Injection 5000 KU Powder for Injection 10000 KU 7.1.28 Lenalidomide T Capsule 5 mg Capsule 25 mg 7.1.29 Melphalan T Tablet 2 mg Tablet 5 mg 7.1.30 Methotrexate** S,T Tablet 2.5 mg Tablet 5 mg Tablet 10 mg Injection 50 mg/mL *Hydroxyurea formulations are also listed in Section 8.1.6 - Medicines affecting Blood Antianaemia Medicines **Methotrexate formulations are also listed in Section 2.4.3 - Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Disease Modifying Agents used in Rheumatoid Disorders Medicine Level of Healthcare Dosage form(s) and strength(s) 7.1.31 Oxaliplatin T Injection 5 mg/mL in 10 mL vial Injection 5 mg/mL in 20 mL vial 7.1.32 Paclitaxel T Injection 30 mg/5 mL Injection 100 mg/16.7 mL 7.1.33 Rituximab T Injection 10 mg/mL 7.1.34 Temozolomide T Capsule 20 mg Capsule 100 mg Capsule 250 mg 7.1.35 Thalidomide T Capsule 50 mg Capsule 100 mg 7.1.36 Trastuzumab T Injection 440 mg/50 mL 7.1.37 Vinblastine T Injection 1 mg/mL 7.1.38 Vincristine T Injection 1 mg/mL 7.2-Hormones and Anti-hormones used in Cancer Therapy Medicine Level of Healthcare Dosage form(s) and strength(s) 7.2.1 Bicalutamide T Tablet 50 mg 7.2.2 Letrozole T Tablet 2.5 mg Medicine Level of Healthcare Dosage form(s) and strength(s) 7.2.3 Leuprolide acetate T Powder for injection 3.75 mg Powder for injection 11.25 mg Powder for injection 22.5 mg 7.2.4 Prednisolone* S,T Tablet 10 mg Tablet 20 mg Tablet 40 mg Oral liquid 5 mg/5 mL (p) Oral liquid 15 mg/5 mL (p) Injection 20 mg/2 mL 7.2.5 Tamoxifen T Tablet 10 mg Tablet 20 mg 7.3 - Immunosuppressive Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 7.3.1 Azathioprine** T Tablet 50 mg 7.3.2 Cyclosporine T Capsule 25 mg Capsule 50 mg Capsule 100 mg Oral liquid 100 mg/mL (p) Injection 50 mg/mL *Prednisolone formulations are also listed in - A. Section 3.6 - Antiallergics and Medicines used in Anaphylaxis B. Section 18.1.5 - Hormones, other Endocrine Medicines and Contraceptives -Adrenal Hormones and synthetic substitutes C. Section 21.2.1 - Ophthalmological Medicines - Antiinflammatory Medicine **Azathioprine formulations are also listed in Section 2.4.1 - Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Disease Modifying Agents used in Rheumatoid Disorders Medicine Level of Healthcare Dosage form(s) and strength(s) 7.3.3 Mycophenolate mofetil T Tablet 250 mg Tablet 500 mg 7.3.4 Tacrolimus T Capsule 0.5 mg Capsule 1 mg Capsule 2 mg 7.4-Medicines used in Palliative Care Medicine Level of Healthcare Dosage form(s) and strength(s) 7.4.1 Allopurinol* S,T Tablet 100 mg 7.4.2 Amitriptyline** S,T Tablet 10 mg Tablet 25 mg 7.4.3 Dexamethasone*** S,T Tablet 0.5 mg Tablet 4 mg Injection 4 mg/mL *Allopurinol formulations are also listed in Section 2.3.1 - Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs),Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Medicines used to treat Gout **Amitriptyline formulations are also listed in A. Section 5.2.5 - Medicines used in Neurological Disorders - Anti-migraine medicines - For prophylaxis B. Section 23.2.1.1 - Medicines in treatment of Psychiatric Disorders -Medicines used in mood disorders- Medicines used in depressive disorders ***Dexamethasone formulations are also listed in A. Section 3.4 - Antiallergics and medicines used in anaphylaxis B. Section 18.1.1 - Hormones, other Endocrine Medicines and Contraceptives - Adrenal hormones and synthetic substitutes C. Section 27.1 - Medicines for COVID 19 management Medicine Level of Healthcare Dosage form(s) and strength(s) 7.4.4 Diazepam* S,T Tablet 2 mg Tablet 5 mg Injection 5 mg/mL 7.4.5 Filgrastim T Injection 300 mcg 7.4.6 Fluoxetine** S,T Capsule 20 mg 7.4.7 Haloperidol*** S,T Tablet 1.5 mg Tablet 5 mg Injection 5 mg/mL 7.4.8 Lactulose**** S,T Oral liquid 10 g/15 mL 7.4.9 Loperamide S,T Tablet 2 mg *Diazepam formulations are also listed Section 5.1.3 - Medicines used in Neurological Disorders - Anticonvulsants/Antiepileptics **Fluoxetine formulations are also listed in A. Section 23.2.1.3 - Medicines in used in treatment of Psychiatric Disorders - Medicines used in mood disorders - Medicines used in depressive disorders B. Section 23.4.2 - Medicines used in treatment of Psychiatric Disorders - Medicines used in obsessive compulsive disorders and panic attacks ***Haloperidol formulations are also listed in Section 23.1.3 - Medicines used in treatment of psychiatric Disorders - Medicines used in psychotic disorders ****Lactulose formulations are also listed in Section 17.5.3 - Gastrointestinal Medicines - Laxatives Medicine Level of Healthcare Dosage form(s) and strength(s) 7.4.10 Metoclopramide* S,T Tablet 10 mg Oral liquid 5 mg/5 mL (p) Injection 5 mg/mL 7.4.11 Mesna T Injection 100 mg/mL 7.4.12 Midazolam** S,T Injection 1 mg/mL 7.4.13 Morphine*** S,T Tablet 10 mg Modified Release Tablet 30 mg 7.4.14 Ondansetron**** S,T Tablet 4 mg Tablet 8 mg Oral liquid 2 mg/5 mL (p) Injection 2 mg/mL *Metoclopramide formulations are also listed in Section 17.2.2 - Gastrointestinal Medicines Antiemetics **Midazolam formulations are also listed in - A. Section 1.3.3 - Medicines used in Anaesthesia - Preoperative medication and sedation for short term procedures B. Section 5.1.7 - Medicines used in Neurological Disorders -Anticonvulsants/Antiepileptics ***Morphine formulations are also listed in - A. Section 1.3.4 - Medicines used in Anaesthesia - Preoperative medication and sedation for short term procedures B. Section 2.2.2 - Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Opioid Analgesics ****Ondansetron formulations are also listed Section 17.2.3 - Gastrointestinal Medicines anti-ulcer medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 7.4.15 Tramadol* S,T Capsule 50 mg Capsule 100 mg Injection 50 mg/mL 7.4.16 Zoledronic acid T Powder for Injection 4 mg Section 8 Medicines affecting Blood 8.1- Antianaemia Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 8.1.1 Erythropoietin S,T Injection 2000 IU/mL Injection 10000 IU/mL 8.1.2 Ferrous salts (a) Iron Dextran (b) Iron sorbitol citrate complex P,S,T Tablet equivalent to 60 mg of elemental iron Injection 50 mg/mL Injection 50 mg/mL 8.1.3 Ferrous Salt (A)+ Folic acid (B) P,S,T Tablet 45 mg elemental iron (A) + 400 mcg (B) Tablet 100 mg elemental iron (A) + 500 mcg (B) Oral liquid 20 mg elemental iron (A) + 100 mcg/mL (B) (p) *Tramadol formulations are also listed in Section 2.2.3 - Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and disease Modifying agents used in Rheumatoid Disorders- Opioid Analgesics Medicine Level of Healthcare Dosage form(s) and strength(s) 8.1.4 Folic Acid P,S,T Tablet 1 mg Tablet 5 mg 8.1.5 Hydroxocobalamin P,S,T Injection 1 mg/mL 8.1.6 Hydroxyurea* S,T Capsule 500 mg 8.1.7 Iron sucrose S,T Injection 20 mg/mL 8.2 - Medicines affecting Coagulation Medicine Level of Healthcare Dosage form(s) and strength(s) 8.2.1 Enoxaparin** S,T Injection 40 mg/ 0.4 mL Injection 60 mg/ 0.6 mL 8.2.2 Heparin*** S,T Injection 1000 IU/mL Injection 5000 IU/mL 8.2.3 Phytomenadione (Vitamin K1) P,S,T Tablet 10 mg Injection 10 mg/mL 8.2.4 Protamine Sulphate S,T Injection 10 mg/mL 8.2.5 Tranexamic acid P,S,T Tablet 500 mg Injection 100 mg/mL * Hydroxyurea formulations are also listed in Section 7.1.26 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Antineoplastic medicines ** Enoxaparin formulations are also listed in A. Section 10.5.4 - Cardiovascular Medicines - Antiplatelet and Antithrombotic Medicines B. Section 27.2 - Medicines for COVID 19 management *** Heparin formulations are also listed in Section 10.5.5 - Cardiovascular Medicines - Antiplatelet and Antithrombotic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 8.2.6 Warfarin S,T Tablet 1 mg Tablet 2 mg Tablet 3 mg Tablet 5 mg Section 9 Blood products and Plasma substitutes 9.1 - Blood and Blood components All forms of the following as approved by licensing authority are considered as included in NLEM. However, considering the process, technology and other relevant aspects, they should be considered differently for purposes such as procurement policy, pricing etc. Medicine Level of Healthcare Dosage form(s) and strength(s) 9.1.1 Fresh frozen plasma S,T As licensed 9.1.2 Platelet rich plasma/ Platelet concentrates S,T As licensed 9.1.3 Red blood cells/ Packed RBCs S,T As licensed 9.1.4 Whole blood S,T As licensed 9.2 - Plasma substitutes Medicine Level of Healthcare Dosage form(s) and strength(s) 9.2.1 Dextran-40 S,T Injection 10 % 9.3 - Plasma fractions for specific use In case of coagulation factors and other blood products, irrespective of variation in source, all forms of these products as approved by licensing authority are considered as included in NLEM. However, considering the source, process, technology and other relevant aspects, they should be considered differently for purposes such as procurement policy, pricing etc. Medicine Level of Healthcare Dosage form(s) and strength(s) 9.3.1 Coagulation factor IX S,T Powder for Injection 600 IU 9.3.2 Coagulation factor VIII S,T Powder for Injection 250 IU Powder for Injection 500 IU 9.3.3 Cryoprecipitate S,T As licensed Section 10 Cardiovascular Medicines 10.1-Medicines used in Angina Medicine Level of Healthcare Dosage form(s) and strength(s) 10.1.1 Diltiazem P,S,T Tablet 30 mg Tablet 60 mg Modified Release Tablet 180 mg S, T Injection 5 mg/mL 10.1.2 Glyceryl trinitrate P,S,T Sublingual Tablet 0.5 mg S,T Injection 5 mg/mL 10.1.3 Isosorbide dinitrate P,S,T Tablet 5 mg Tablet 10 mg 10.1.4 Metoprolol P,S,T Tablet 25 mg Tablet 50 mg Tablet 100 mg Modified Release Tablet 100 mg S,T Injection 1 mg/mL 10.2 - Antiarrhythmic medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 10.2.1 Adenosine S,T Injection 3 mg/mL 10.2.2 Amiodarone S,T Tablet 100 mg Tablet 200 mg Injection 50 mg/mL 10.2.3 Digoxin* S,T Tablet 0.25 mg Oral liquid 0.05 mg/mL Injection 0.25 mg/mL 10.2.4 Esmolol S,T Injection 10 mg/mL 10.2.5 Lignocaine** S,T Injection 2% 10.2.6 Verapamil S,T Tablet 40 mg Tablet 80 mg Injection 2.5 mg/ mL 10.3 - Antihypertensive Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 10.3.1 Amlodipine P,S,T Tablet 2.5 mg Tablet 5 mg Tablet 10 mg *Digoxin formulations are also listed in Section 10.4.1 - Cardiovascular Medicines - Medicines used in Shock and Heart Failure **Lignocaine formulations are also listed in Section 1.2.2 - Medicines used in Anaesthesia - Local Anaesthetics Medicine Level of Healthcare Dosage form(s) and strength(s) 10.3.2 Enalapril P,S,T Tablet 2.5 mg Tablet 5 mg 10.3.3 Hydrochlorothiazide * P,S,T Tablet 12.5 mg Tablet 25 mg 10.3.4 Labetalol P,S,T Tablet 50 mg Tablet 100 mg P,S,T Injection 5 mg/mL 10.3.5 Ramipril P,S,T Tablet 2.5 mg Tablet 5 mg 10.3.6 Sodium nitroprusside S, T Injection 10 mg/mL 10.3.7 Telmisartan P,S,T Tablet 20 mg Tablet 40 mg Tablet 80 mg 10.4 - Medicines used in Shock and Heart failure Medicine Level of Healthcare Dosage form(s) and strength(s) 10.4.1 Digoxin** S,T Tablet 0.25 mg Oral liquid 0.05 mg/mL Injection 0.25 mg/mL *Hydrochlorothiazide formulations are also listed in Section 15.2 - Diuretics **Digoxin formulations are also listed in Section 10.2.3 - Cardiovascular Medicines - Antiarrhythmic medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 10.4.2 Dobutamine S,T Injection 50 mg/mL 10.4.3 Dopamine S,T Injection 40 mg/mL 10.4.4 Noradrenaline S,T Injection 2 mg/mL 10.4.5 Spironolactone* P,S,T Tablet 25 mg Tablet 50 mg 10.5- Antiplatelet and Antithrombotic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 10.5.1 Acetylsalicylic acid** P,S,T Conventional/Effervescent/ Dispersible/ Enteric coated Tablets 150 mg Conventional/Effervescent/ Dispersible/ Enteric coated Tablets 325 mg Enteric coated Tablet 75 mg Enteric coated Tablet 100 mg *Spironolactone formulations are also listed in Section 15.4 - Diuretics **Acetylsalicyclic acid formulations are also listed in - A. Section 2.1.1 - Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs B. Section 5.2.1 - Medicines used in Neurological Disorders- Antimigraine medicines 10.5.2 Clopidogrel P,S,T Tablet 75 mg Tablet 150 mg 10.5.3 Dabigatran S, T Tablet 110 mg Tablet 150 mg 10.5.4 Enoxaparin* S,T Injection 40 mg/ 0.4 mL Injection 60 mg/ 0.6 mL 10.5.5 Heparin** S,T Injection 1000 IU/mL Injection 5000 IU/mL 10.5.6 Streptokinase S,T Injection 750,000 IU Injection 15,00,000 IU 10.5.7 Tenecteplase S,T Injection 30 mg/vial Injection 40 mg/vial 10.6 - Hypolipidemic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 10.6.1 Atorvastatin P,S,T Tablet 10 mg Tablet 20 mg Tablet 40 mg Tablet 80 mg *Enoxaparin formulations are also listed in - A. Section 8.2.1 - Medicines affecting Blood - Medicines affecting coagulation B. Section 27.2 - Medicines for COVID 19 management **Heparin formulations are also listed in Section 8.2.2 - Medicines affecting Blood - Medicines affecting coagulation Section 11 Dermatological Medicines (Topical) 11.1 - Antifungal Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 11.1.1 Clotrimazole* P,S,T Cream 1 % Lotion 1 % 11.2 - Antibacterial Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 11.2.1 Framycetin P,S,T Cream 1 % 11.2.2 Fusidic acid P,S,T Cream 2 % 11.2.3 Silver sulphadiazine P,S,T Cream 1 % 11.3-Antiinflammatory and Antipruritic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 11.3.1 Betamethasone valerate P,S,T Cream 0.05 % Cream 0.1 % *Clotrimazole formulations are also listed in - A. Section 6.5.2 - Anti-infective Medicines -Antifungal medicines B. Section 6.7.5.4 - Anti-infective Medicines Antiviral medicines- Medicines used in the management of HIV C. Section 16.3 - Ear, Nose and ThroatMedicines Medicine Level of Healthcare Dosage form(s) and strength(s) 11.3.2 Calamine P,S,T Lotion (As per IP) 11.4 - Keratolytic agents Medicine Level of Healthcare Dosage form(s) and strength(s) 11.4.1 Benzoyl peroxide P,S,T Gel 2.5 % - 5 % 11.4.2 Coal tar (A) + Salicylic Acid (B) P,S,T Solution 1 % (A) + 3 % (B) 11.4.3 Podophyllin resin S,T Solution 20 % 11.4.4 Salicylic acid P,S,T Ointment 3-6 % 11.5 - Scabicides and Pediculicides Medicine Level of Healthcare Dosage form(s) and strength(s) 11.5.1 Permethrin P,S,T Lotion 1 % Cream 5 % 11.6 Miscellaneous Medicine Level of Healthcare Dosage form(s) and strength(s) 11.6.1 Glycerin/glycerol (as mentioned in IP) P,S,T Topical Section 12 Diagnostic agents 12.1 - Ophthalmic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 12.1.1 Fluorescein S,T Ophthalmic Strips 12.1.2 Proparacaine* S,T Eye Drops 0.5% 12.1.3 Tropicamide** S,T Eye drop 1 % 12.2 - Radiocontrast Media 12.2.1 Barium sulphate S,T Oral Liquid 95% w/v 12.2.2 Gadobenate dimeglumine T Injection 529 mg/mL 12.2.3 Iohexol S,T Injection 140 to 350 mg iodine/mL 12.2.4 Meglumine diatrizoate S,T Injection 60 % w/v Injection 76 % w/v * Proparacaine formulations are also listed in Section 21.3.1 - Ophthalmological Medicines- Local Anaesthetics ** Tropicamide formulations are also listed in Section 21.5.4 - Ophthalmological Medicines Mydriatics Section 13 Dialysis components (Haemodialysis and Peritoneal Dialysis) Medicine Level of Healthcare Dosage form(s) and strength(s) 13.1 Haemodialysis fluid S,T As licensed 13.2 Peritoneal dialysis solution S,T As licensed Section 14 Antiseptics and Disinfectants 14.1 Antiseptics Medicine Level of Healthcare Dosage form(s) and strength(s) 14.1.1 Chlorhexidine P,S,T Solution 5% (Concentrate) 14.1.2 Ethyl alcohol (Denatured) P,S,T Solution 70% 14.1.3 Hydrogen peroxide P,S,T Solution 6 % 14.1.4 Methylrosanilinium chloride (Gentian Violet) P,S,T Topical preparation 0.25% to 2% 14.1.5 Povidone iodine* P,S,T Solution 4 % to 10 % *Povidone Iodine formulations are also listed in Section 21.1.5 - Ophthalmological Medicines - Anti-infective medicine 14.2 Disinfectants Medicine Level of Healthcare Dosage form(s) and strength(s) 14.2.1 Glutaraldehyde S,T As Licensed 14.2.2 Potassium permanganate P,S,T Crystals for topical solution Section 15 Diuretics Medicine Level of Healthcare Dosage form(s) and strength(s) 15.1 Furosemide P,S,T Tablet 40 mg Oral liquid 10 mg/mL Injection 10 mg/ mL 15.2 Hydrochlorothiazide * P,S,T Tablet 25 mg Tablet 50 mg 15.3 Mannitol P,S,T Injection 10 % Injection 20 % 15.4 Spironolactone** P,S,T Tablet 25 mg Tablet 50 mg * Hydrochlorothiazide formulations are also listed in Section 10.3.3 - Antihypertensive Medicines **Spironolactone formulations are also listed in Section 10.4.5 - Cardiovascular Medicines - Medicines used in shock and heart failure Section 16 Ear, Nose and Throat Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 16.1 Budesonide* P,S,T Nasal Spray 50 mcg/dose Nasal Spray 100 mcg/dose 16.2 Ciprofloxacin** P,S,T Drops 0.3 % 16.3 Clotrimazole*** P,S,T Drops 1 % 16.4 Xylometazoline P,S,T Nasal drops 0.05 % Nasal drops 0.1 % *Budesonide formulations are also listed in Section 24.1 - Medicines acting on the respiratory tract - Antiasthmatic Medicines **Ciprofloxacin formulations are also listed in A. Section 6.2.2.3 - Anti-infective Medicines- Antibacterials -Other Antibacterials B. Section 21.1.2 - Ophthalmological Medicines- Anti-infective Medicines ***Clotrimazole formulations are also listed in - A. Section 6.5.2 - Anti-infective Medicines -Antifungal medicines B. Section 6.7.5.4 - Anti-infective Medicines Antiviral medicines- Medicines used in the management of HIV C. Section 11.1.1 - Dermatological Medicines (Topical) -Antifungal medicines Section 17 Gastrointestinal Medicines 17.1 - Antiulcer Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 17.1.1 Omeprazole P,S,T Capsule 10 mg Capsule 20 mg Capsule 40 mg Powder for oral liquid 20 mg 17.1.2 Pantoprazole S,T Injection 40 mg 17.2 Antiemetics Medicine Level of Healthcare Dosage form(s) and strength(s) 17.2.1 Domperidone P,S,T Tablet 10 mg Oral Liquid 1 mg/mL 17.2.2 Metoclopramide* P,S,T Tablet 10 mg Injection 5 mg/mL 17.2.3 Ondansetron* S,T Tablet 4 mg Oral Liquid 2 mg/5 mL (p) Injection 2 mg/ mL *Metoclopramide formulations are also listed in Section 7.4.10 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Medicines used in Palliative Care *Ondansetron formulations are also listed in Section 7.4.14 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Medicines used in Palliative Care 17.3 Anti-inflammatory medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 17.3.1 5-aminosalicylic acid (Mesalazine/ Mesalaine) S, T Tablet 400 mg Suppository 500 mg Retention Enema 17.4 Antispasmodic medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 17.4.1 Dicyclomine P,S,T Tablet 10 mg Oral Solution 10 mg/5mL Injection 10 mg/ mL 17.4.2 Hyoscine butyl bromide P,S,T Tablet 100 mg Injection 20 mg/ mL 17.5 Laxatives Medicine Level of Healthcare Dosage form(s) and strength(s) 17.5.1 Bisacodyl P,S,T Tablet 5 mg Suppository 5 mg 17.5.2 Ispaghula P,S,T Granules/ Husk/ Powder Medicine Level of Healthcare Dosage form(s) and strength(s) 17.5.3 Lactulose* S,T Oral Liquid 10 g/15 mL 17.6 Medicines used in diarrhea Medicine Level of Healthcare Dosage form(s) and strength(s) 17.6.1 Oral rehydration salts** P,S,T As licensed 17.6.2 Zinc Sulphate P,S,T Dispersible Tablet 20 mg 17.7 Other medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 17.7.1 Somatostatin T Powder for Injection 3 mg *Lactulose formulations are also listed in Section 7.4.8 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care **Oral rehydration salts formulations are also listed in Section 25.3 - Solutions correcting water, electrolyte disturbances and acid-base disturbances Section 18 Hormones, other Endocrine Medicines and Contraceptives 18.1-Adrenal Hormones and Synthetic substitutes Medicine Level of Healthcare Dosage form(s) and strength(s) 18.1.1 Dexamethasone* S,T Tablet 0.5 mg Injection 4 mg/mL 18.1.2 Fludrocortisone S,T Tablet 0.1 mg 18.1.3 Hydrocortisone** P,S,T Tablet 5 mg Tablet 10 mg Tablet 20 mg Powder for Injection 100 mg 18.1.4 Methylprednisolone *** S,T Injection 40mg/mL *Dexamethasone formulations are also listed in - A. Section 3.4 - Antiallergics and Medicines used in Anaphylaxis B. Section 7.4.3 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care C. Section 27.1 - Medicines for COVID 19 Management ** Hydrocortisone formulations are also listed in Section 3.5 - Antiallergics and Medicines used in Anaphylaxis *** Methylprednisolone formulations are also listed in section 27.3- Medicines for COVID - 19 management Medicine Level of Healthcare Dosage form(s) and strength(s) 18.1.5 Prednisolone* P,S,T Tablet 5 mg Tablet 10 mg Tablet 20 mg Oral liquid 5 mg/5 mL (p) Oral liquid 15 mg/5 mL (p) 18.2 Contraceptives 18.2.1 - Hormonal Contraceptives Medicine Level of Healthcare Dosage form(s) and strength(s) 18.2.1.1 Ethinylestradiol (A)+ Levonorgestrel (B) P,S,T Tablet 0.03 mg (A) + Tablet 0.15 mg (B) 18.2.1.2 Levonorgestrel P,S,T Tablet 0.75 mg Tablet 1.5 mg 18.2.1.3 Ormeloxifene (Centchroman) P,S,T Tablet 30 mg *Prednisolone formulations are also listed in - A. Section 3.7 - Antiallergics and Medicines used in Anaphylaxis B. Section 7.2.4 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Hormones and anti- hormones used in cancer therapy C. Section 21.2.1 - Ophthalmological Medicines - Antiinflammatory medicine 18.2.2 - Intrauterine Devices Medicine Level of Healthcare Dosage form(s) and strength(s) 18.2.2.1 Hormone releasing IUD T Contains 52 mg of Levonorgestrel 18.2.2.2 IUD containing Copper P,S,T As licensed 18.2.3 - Barrier methods Medicine Level of Healthcare Dosage form(s) and strength(s) 18.2.3.1 Condom P,S,T As Licensed as per the standards of Drugs Rules, 1945 18.3 - Medicines used in Diabetes Mellitus 18.3.1 - Insulins and other Antidiabetic agents Medicine Level of Healthcare Dosage form(s) and strength(s) 18.3.1.1 Glimepiride P,S,T Tablet 1 mg Tablet 2 mg 18.3.1.2 Insulin (Soluble) P,S,T Injection 40 IU/mL 18.3.1.3 Insulin Intermediate Acting (NPH) P,S,T Injection 40 IU/mL Medicine Level of Healthcare Dosage form(s) and strength(s) 18.3.1.4 Insulin Glargine P,S,T Injection 100 IU/mL 18.3.1.5 Insulin Premix Injection 30:70 (Regular : NPH) P,S,T Injection 40 IU/mL 18.3.1.6 Metformin P,S,T Tablet 500 mg Tablet 1000 mg Modified release Tablet 1000 mg 18.3.1.7 Teneligliptin P,S,T Tablet 20 mg 18.3.2 - Medicines used to treat Hypoglycemia Medicine Level of Healthcare Dosage form(s) and strength(s) 18.3.2.1 Glucose* P,S,T Injection 25 % 18.4-Ovulation Inducers Medicine Level of Healthcare Dosage form(s) and strength(s) 18.4.1 Clomiphene citrate T Tablet 50 mg Tablet 100 mg 18.4.2 Human chorionic gonadotropin S,T Injection 2000 IU Injection 5000 IU Injection 10000 IU *Glucose formulations are also listed in Section 25.1 - Solutions correcting water, electrolyte disturbances and acid-base disturbances 18.5-Progestogens Medicine Level of Healthcare Dosage form(s) and strength(s) 18.5.1 Medroxyprogesterone acetate P,S,T Tablet 5 mg Tablet 10 mg Injection 150 mg/ mL 18.5.2 Norethisterone P,S,T Tablet 5 mg 18.6-Thyroid and Antithyroid Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 18.6.1 Carbimazole P,S,T Tablet 5 mg Tablet 10 mg Tablet 20 mg 18.6.2 Levothyroxine P,S,T Tablet 12.5 mcg to 150 mcg* (*Several strengths are available in market such as 12.5,25,50,62.5, 75, 88,100, 112mcg. Therefore, it was considered to give a range of available strengths) Section 19 Immunologicals In case of these biologicals, irrespective of variation in source, composition and strengths, all the products of the same vaccine/ sera/ immunoglobulin, as approved by licensing authority are considered as included in NLEM. However, considering the source, process, technology and other relevant aspects, different products of the same biological should be considered differently for purposes such as procurement policy, pricing etc. 19.1-Diagnostic agents Medicine Level of Healthcare Dosage form(s) and strength(s) 19.1.1 Tuberculin, Purified Protein derivative P,S,T As Licensed 19.2-Sera and Immunoglobulins (Liquid/ Lyophilized) Medicine Level of Healthcare Dosage form(s) and strength(s) 19.2.1 Anti-rabies immunoglobulin P,S,T As Licensed 19.2.2 Anti-tetanus immunoglobulin P,S,T As Licensed 19.2.3 Anti-D immunoglobulin S,T As Licensed 19.2.4 Diphtheria antitoxin P,S,T As Licensed 19.2.5 Hepatitis B immunoglobulin S,T As Licensed 19.2.6 Human normal immunoglobulin T As Licensed 19.2.7 Snake Venom Antiserum* P,S,T a) Soluble/ liquid polyvalent - As Licensed b) Lyophilized polyvalent - As Licensed *Snake Venom antiserum also listed in Section 4.2.12 - Antidotes and Other Substances used in Management of Poisonings/Envenomation Specific 19.3-Vaccines a) All the vaccines which are under Universal Immunization Program of India (UIP) will be deemed included in NLEM. Presently, the UIP has BCG, DPT, OPV, measles, Hepatitis B, Japanese encephalitis, Pentavalent Vaccines and Rota virus vaccine. b) The vaccines, which have been approved by National Technical Advisory Group on Immunization (NTAGI) and planned to be given under UIP, will be deemed to be included as and when listed in UIP. These vaccines are inactivated polio vaccine (IPV) and Measles Rubella (MR). c) In future, the vaccines which are under consideration, if and when included in UIP, will also be deemed included from the date of inclusion in UIP. These are pneumococcal and HPV vaccines. For Universal Immunization Medicine Level of Healthcare Dosage form(s) and strength(s) 19.3.1 BCG vaccine P,S,T As licensed 19.3.2 DPT+ Hib+ Hep B vaccine P,S,T As licensed 19.3.3 DPT vaccine P,S,T As licensed 19.3.4 Hepatitis B vaccine P,S,T As licensed 19.3.5 Japanese encephalitis vaccine P,S,T As licensed Medicine Level of Healthcare Dosage form(s) and strength(s) 19.3.6 Measles vaccine P,S,T As licensed 19.3.7 Oral poliomyelitis vaccine P,S,T As licensed 19.3.8 Rotavirus vaccine P,S,T As licensed 19.3.9 Tetanus toxoid P,S,T As licensed 19.4 - For Specific Group of Individuals Medicine Level of Healthcare Dosage form(s) and strength(s) 19.4.1 Rabies vaccine P,S,T As licensed Section 20 Medicines for Neonatal Care Medicine Level of Healthcare Dosage form(s) and strength(s) 20.1 Alprostadil S,T Injection 0.5 mg/mL 20.2 Caffeine S,T Oral liquid 20 mg/mL Injection 20 mg/mL 20.3 Surfactant S,T Suspension for intratracheal instillation (As licensed) Section 21 Ophthalmological Medicines 21.1-Anti-infective Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 21.1.1 Acyclovir* P,S,T Ointment 3% 21.1.2 Ciprofloxacin** P,S,T Drops 0.3% Ointment 0.3% 21.1.3 Natamycin P,S,T Drops 5 % 21.1.4 Povidone iodine*** P,S,T Drops 5 % 21.2-Antiinflammatory Medicine Medicine Level of Healthcare Dosage form(s) and strength(s) 21.2.1 Prednisolone**** P,S,T Drops 1 % *Acyclovir formulations are also listed in - A. Anti-infective Medicines -Antiviral medicines -Anti-herpes medicines Section 6.6.1.1 B. Anti-infective Medicines -Medicines used in the management of HIV -Medicines for treating Opportunistic Infections in People living with HIV Section 6.7.5.1 **Ciprofloxacin formulations are also listed in - A. Section 6.2.2.3 - Anti-infective Medicines- Antibacterials - Other Antibacterials B. Section 16.2 Ear, Nose and Throat Medicines ***Povidone Iodine Also listed in Section 14.1.5 - Antiseptics and Disinfectants- Antiseptics ****Prednisolone formulations are also listed in - A. Section 3.7 - Antiallergics and Medicines used in Anaphylaxis B. Section 7.2.4 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Hormones and anti-hormones used in cancer therapy C. Section 18.1.5 - Hormones, other Endocrine Medicines and Contraceptives- Adrenal Hormones and synthetic substitutes 21.3- Local Anaesthetic Medicine Level of Healthcare Dosage form(s) and strength(s) 21.3.1 Proparacaine* P,S,T Drops 0.5 % 21.4-Miotics and Antiglaucoma Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 21.4.1 Acetazolamide P,S,T Tablet 250 mg 21.4.2 Latanoprost P,S,T Drops 0.005 % 21.4.3 Pilocarpine P,S,T Drops 2 % Drops 4 % 21.4.4 Timolol P,S,T Drops 0.25 % Drops 0.5 % 21.5-Mydriatics Medicine Level of Healthcare Dosage form(s) and strength(s) 21.5.1 Atropine** P,S,T Drops 1% Ointment 1% *Proparacaine formulations are also listed in listed in Section 12.1.2 - Diagnostic agents- Ophthalmic Medicines **Atropine formulations are also listed in - A. Section 1.3.1 - Medicines used in Anaesthesia -Preoperative medication and sedation for short term procedures B. Section 4.2.1 - Antidotes and Other substances used in Management of poisoning/Envenomation - specific Medicine Level of Healthcare Dosage form(s) and strength(s) 21.5.2 Homatropine P,S,T Drops 2% 21.5.3 Phenylephrine P,S,T Drops 5 % Drops 10 % 21.5.4 Tropicamide* P,S,T Drops 1 % 21.6-Miscellaneous Medicine Level of Healthcare Dosage form(s) and strength(s) 21.6.1 Carboxymethyl cellulose P,S,T Drops 0.5% Drops 1% 21.6.2 Hydroxypropyl methylcellulose T Injection 2% Section 22 Oxytocics and Antioxytocics 22.1 - Oxytocics and Abortifacient Medicine Level of Healthcare Dosage form(s) and strength(s) 22.1.1 Dinoprostone S,T Tablet 0.5 mg Gel 0.5 mg 22.1.2 Methylergometrine P,S,T Tablet 0.125 mg Injection 0.2 mg/mL *Tropicamide formulations are also listed in Section 12.1.3 - Diagnostic agents - Ophthalmic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 22.1.3 Mifepristone P,S,T Tablet 200 mg 22.1.4 Misoprostol P,S,T Tablet 100 mcg Tablet 200 mcg 22.1.5 Oxytocin P,S,T Injection 5 IU/mL Injection 10 IU/mL 22.2 - Medicines used in Preterm Labour Medicine Level of Healthcare Dosage form(s) and strength(s) 22.2.1 Betamethasone P,S,T Injection 4 mg/mL 22.2.2 Nifedipine S,T Tablet 10 mg Section 23 Medicines used in treatment of Psychiatric Disorders 23.1 - Medicines used in Psychotic Disorders Medicine Level of Healthcare Dosage form(s) and strength(s) 23.1.1 Clozapine T Tablet 25 mg Tablet 50 mg Tablet 100 mg 23.1.2 Fluphenazine P,S,T Injection 25 mg/mL Medicine Level of Healthcare Dosage form(s) and strength(s) 23.1.3 Haloperidol* S,T Tablet 2 mg Tablet 5 mg Tablet 10 mg Tablet 20 mg Oral liquid 2 mg/5 mL Injection 5 mg/mL 23.1.4 Risperidone P,S,T Tablet 1 mg Tablet 2 mg Tablet 4 mg Oral liquid 1 mg/mL Injection (Long acting) 25 mg Injection (Long acting) 37.5 mg 23.2 - Medicines used in Mood Disorders 23.2.1 - Medicines used in Depressive Disorders Medicine Level of Healthcare Dosage form(s) and strength(s) 23.2.1.1 Amitriptyline** P,S,T Tablet 10 mg Tablet 25 mg Tablet 50 mg Tablet 75 mg *Haloperidol formulations are also listed in Section 7.4.7 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care **Amitriptyline formulations are also listed in - A. Section 5.2.5 - Medicines used in Neurological Disorders - Anti-migraine medicines- For prophylaxis B. Section 7.4.2 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care Medicine Level of Healthcare Dosage form(s) and strength(s) 23.2.1.2 Escitalopram P,S,T Tablet 5 mg Tablet 10 mg Tablet 20 mg 23.2.1.3 Fluoxetine* P,S,T Capsule 10 mg Capsule 20 mg Capsule 40 mg Capsule 60 mg 23.2.2 - Medicines used in Bipolar Disorders Medicine Level of Healthcare Dosage form(s) and strength(s) 23.2.2.1 Lithium S,T Tablet 300 mg 23.2.2.2 Sodium valproate** P,S,T Tablet 200 mg Tablet 300 mg Tablet 500 mg Modified Release - Tablet 300 mg Tablet 500 mg 23.2.2.3 Carbamazepine*** P,S,T Tablet 100 mg Tablet 200 mg Tablet 400 mg Modified Release - Tablet 200 mg Tablet 400 mg Oral liquid 100 mg/5 mL (p) *Fluoxetine formulations are also listed in - A. Section 7.4.6 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care B. Section 7.4.6 - Medicines used in treatment of psychiatric Disorders - Medicines used in obsessive compulsive disorders and panic attacks ** Sodium Valproate formulations are also listed in Section 5.1.10 - Medicines used in Neurological Disorders -Anticonvulsants /antiepileptics ***Carbamazepine formulations are also listed in Section 5.1.1 - Medicines used in Neurological Disorders- Anticonvulsants/antiepileptics 23.3 - Medicines used in Generalized Anxiety and Sleep Disorders Medicine Level of Healthcare Dosage form(s) and strength(s) 23.3.1 Clonazepam P,S,T Tablet 0.25 mg Tablet 0.5 mg Tablet 1 mg 23.3.2 Zolpidem P,S,T Tablet 5 mg Tablet 10 mg 23.4 - Medicines used in Obsessive Compulsive Disorders and Panic attacks Medicine Level of Healthcare Dosage form(s) and strength(s) 23.4.1 Clomipramine P,S,T Capsule 10 mg Capsule 25 mg Capsule 75 mg 23.4.2 Fluoxetine* S,T Capsule 10 mg Capsule 20 mg Capsule 40 mg Capsule 60 mg *Fluoxetine formulations are also listed in - A. Section 7.4.6 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care B. Section 23.2.1.3 Medicines used in treatment of Psychiatric Disorders - Medicines used in mood disorders - Medicines used in depressive disorders 23.5 Medicines used in Disorders due to Psychoactive substance abuse Medicine Level of Healthcare Dosage form(s) and strength(s) 23.5.1 Buprenorphine P,S,T Tablet (Sub-lingual) 0.4 mg 23.5.2 Buprenorphine (A) + Naloxone (B) P,S,T Tablet (Sub-lingual) 0.4 mg (A) + 0.1 mg (B) Tablet (Sub-lingual) 2 mg (A) + 0.5 mg (B) 23.5.3 Nicotine (for nicotine replacement therapy) P,S,T Oral Dosage forms 2 mg Oral Dosage forms 4 mg Section 24 Medicines acting on the Respiratory tract 24.1 - Antiasthmatic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 24.1.1 Budesonide* P,S,T Inhalation (MDI/DPI) 100 mcg/dose Inhalation (MDI/DPI) 200 mcg/dose Respirator solution for use in nebulizer 0.5 mg/mL Respirator solution for use in nebulizer 1 mg/mL *Budesonide formulations are also listed in Section 16.1 - Ear, Nose and Throat Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 24.1.2 Budesonide (A) + Formoterol (B) P,S,T Inhalation (MDI/DPI) 100 mcg (A) + 6 mcg (B) Inhalation (MDI/DPI) 200 mcg (A) + 6 mcg (B) Inhalation (MDI/DPI) 400 mcg (A) + 6 mcg (B) 24.1.3 Hydrocortisone* P,S,T Powder for Injection 100 mg Powder for Injection 200 mg 24.1.4 Ipratropium P,S,T Inhalation (MDI/DPI) 20 mcg/dose Respirator solution for use in nebulizer 250 mcg/mL 24.1.5 Montelukast S,T Tablet 4 mg Tablet 5 mg (including chewable tablets) Tablet 10 mg 24.1.6 Salbutamol P,S,T Tablet 2 mg Tablet 4 mg Oral liquid 2 mg/5 mL Inhalation (MDI/DPI*) 100 mcg/dose Respirator Solution (Solution for Nebulizer 5 mg/mL) *Hydrocortisone formulations are also listed in - A. Section 3.5 - Antiallergics and Medicines used in Anaphylaxis B. Section 18.1.3 - Hormones, other Endocrine Medicines and Contraceptives- Adrenal hormones and synthetic substitutes Medicine Level of Healthcare Dosage form(s) and strength(s) 24.1.7 Tiotropium P,S,T Inhalation (MDI) 9 mcg/dose Inhalation (DPI) 18 mcg/dose MDI- Metered Dose Inhaler DPI- Dry Powder Inhaler Section 25 Solutions correcting Water, Electrolyte disturbances and Acid-base disturbances Medicine Level of Healthcare Dosage form(s) and strength(s) 25.1.1 Glucose* P,S,T Injection 5 % Injection 10 % Injection 25 % Injection 50 % 25.1.2 Glucose(A) + Sodium chloride (B) P,S,T Injection 5% (A) + 0.9 % (B) 25.1.3 Oral rehydration salts** P,S,T As licensed 25.1.4 Potassium chloride P,S,T Oral liquid 500 mg/5 mL S,T Injection 150 mg/mL *Glucose formulations are also listed in Section 18.4.2.1 - Hormones, other Endocrine Medicines and Contraceptives - Medicines used in diabetes mellitus - Medicines used to treat hypoglycemia **Oral rehydration salts are also listed in Section 17.6.1 - Gastrointestinal Medicines - Medicines used in diarrhea Medicine Level of Healthcare Dosage form(s) and strength(s) 25.1.5 Ringer lactate P,S,T Injection (as per IP) 25.1.6 Sodium bicarbonate P,S,T Injection (as per IP) 25.1.7 Sodium chloride P,S,T Injection 0.9% S,T Injection 3% 25.2-Miscellaneous Medicine Level of Healthcare Dosage form(s) and strength(s) 25.2.1 Water for Injection P,S,T Injection Section 26 Vitamins and Minerals Medicine Level of Healthcare Dosage form(s) and strength(s) 26.1 Ascorbic acid (Vitamin C) P,S,T Tablet 100 mg Tablet 500 mg 26.2 Calcium carbonate P,S,T Tablet 625 mg (equivalent to elemental calcium 250 mg) Tablet 1250 mg (equivalent to elemental calcium 500 mg) 26.3 Calcium gluconate* P,S,T Injection 100 mg/mL 26.4 Cholecalciferol P,S,T Solid oral dosage form 1000 IU Solid oral dosage form 60000 IU Oral liquid 400 IU/mL *Calcium Gluconate formulations are also listed in Section 4.2.2 - Antidotes and Other substances used in poisoning/Envenomation Specific Medicine Level of Healthcare Dosage form(s) and strength(s) 26.5 Pyridoxine P,S,T Tablet 10 mg Tablet 50 mg Tablet 100 mg 26.6 Riboflavin P,S,T Tablet 10 mg 26.7 Thiamine P,S,T Tablet 100 mg Injection 100 mg/mL 26.8 Vitamin A P,S,T Capsule/Tablet 50000 IU (including Chewable Tablet) Oral liquid 100000 IU/mL Injection 50000 IU/mL Section 27 Medicines for COVID 19 management 27.1 Dexamethasone* P,S,T Tablet 0.5 mg Tablet 2 mg Tablet 4 mg Oral liquid 0.5 mg/5 mL (p) Injection 4 mg/mL 27.2 Enoxaparin** S,T Injection 40 mg/ 0.4 mL Injection 60 mg/ 0.6 mL *Dexamethasone is also listed in - A. Section 3.4 - Antiallergics and Medicines used in Anaphylaxis B. Section 7.4.3 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care C. Section 18.1.1 - Hormones, other Endocrine Medicines and Contraceptives - Adrenal hormones and synthetic substitutes **Enoxaparin is also listed in - A. Section 8.2.1 - Medicines affecting Blood - Medicines affecting coagulation B. Section 10.5.4 - Cardiovascular medicines - Antiplatelet and Antithrombotic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 27.3 Methylprednisolone * S,T Injection 40 mg/mL 27.4 Paracetamol** P,S,T Tablet 500 mg Tablet 650 mg Oral liquid 120 mg/5 mL (p) Oral Liquid 125 mg/5 mL (p) Oral Liquid 250 mg/5 mL (p) 27.5 Oxygen*** P,S,T As licensed for medical purpose *Methylprednisolone is also listed in Section 18.1.4 - Hormones, other Endocrine medicines and Contraceptives- Adrenal Hormones and synthetic substitutes **Paracetamol is also listed in A. Section 2.1.5 - Analgesics, antipyretics, non steroidal anti-inflammatory medicines, medicines used to treat Gout and disease Modifying agents used in Rheumatoid Disorders- Non-opioid analgesics, antipyretics and nonsteroidal anti-inflammatory medicines B. Section 5.2.3 - Medicines used in Neurological Disorders-Antimigraine medicines *** Oxygen is also listed in Medicines used in Section 1.1.5 - Anaesthesia- General Anaesthetics and Oxygen All modified release formulations of same strength such as sustained release, controlled release, extended release, prolonged release etc. are included. Alphabetical List of Medicines in NLEM 2022 Alphabetical List of Medicines in NLEM 2022 1. 5-aminosalicylic acid (Mesalazine/Mesalaine) 2. 5-Fluorouracil 3. 6-Mercaptopurine 4. Abacavir 5. Abacavir (A) + Lamivudine (B) 6. Acetazolamide 7. Acetylsalicylic acid 8. Actinomycin D 9. Activated Charcoal 10. Acyclovir 11. Adenosine 12. Adrenaline 13. Albendazole 14. Allopurinol 15. All-trans retinoic acid 16. Alprostadil 17. Amikacin 18. Amiodarone 19. Amitriptyline 20. Amlodipine 21. Amoxicillin 22. Amoxicillin (A) + Clavulanic acid (B) 23. Amphotericin B a) Amphotericin B (conventional) b) Lipid Amphotericin B c) Liposomal Amphotericin B Alphabetical List of Medicines in NLEM 2022 24. Ampicillin 25. Anti-D immunoglobulin 26. Anti-rabies immunoglobulin 27. Anti-tetanus immunoglobulin 28. Arsenic trioxide 29. Artemether (A) + Lumefantrine (B) 30. Artesunate 31. Artesunate (A) + Sulphadoxine Pyrimethamine (B) 32. Ascorbic acid (Vitamin C) 33. Atazanavir (A) + Ritonavir (B) 34. Atorvastatin 35. Atracurium 36. Atropine 37. Azathioprine 38. Azithromycin 39. Baclofen 40. Barium sulphate 41. BCG vaccine 42. Bedaquiline 43. Bendamustine Hydrochloride 44. Benzathine benzylpenicillin 45. Benzoyl peroxide 46. Benzylpenicillin 47. Betamethasone 48. Betamethasone (valerate) 49. Bicalutamide Alphabetical List of Medicines in NLEM 2022 50. Bisacodyl 51. Bleomycin 52. Bortezomib 53. Budesonide 54. Budesonide (A) +Formoterol (B) 55. Bupivacaine 56. Buprenorphine 57. Buprenorphine (A) + Naloxone (B) 58. Caffeine 59. Calamine 60. Calcium carbonate 61. Calcium folinate 62. Calcium gluconate 63. Capecitabine 64. Carbamazepine 65. Carbimazole 66. Carboplatin 67. Carboxymethyl cellulose 68. Cefadroxil 69. Cefazolin 70. Cefixime 71. Cefotaxime 72. Ceftazidime 73. Ceftriaxone 74. Cefuroxime 75. Cetirizine Alphabetical List of Medicines in NLEM 2022 76. Chlorambucil 77. Chlorhexidine 78. Chloroquine 79. Cholecalciferol 80. Ciprofloxacin 81. Cisplatin 82. Clarithromycin 83. Clindamycin 84. Clobazam 85. Clofazimine 86. Clomiphene citrate 87. Clomipramine 88. Clonazepam 89. Clopidogrel 90. Clotrimazole 91. Cloxacillin 92. Clozapine 93. Coagulation factor IX 94. Coagulation factor VIII 95. Coal tar (A) + Salicylic Acid (B) 96. Colchicine 97. Condom 98. Co-trimoxazole [Sulphamethoxazole (A) + Trimethoprim (B)] 99. Cryoprecipitate 100. Cyclophosphamide Alphabetical List of Medicines in NLEM 2022 101. Cycloserine 102. Cyclosporine 103. Cytosine arabinoside 104. D- Penicillamine 105. Dabigatran 106. Dacarbazine 107. Daclatasvir 108. Dapsone 109. Darunavir 110. Darunavir (A) + Ritonavir (B) 111. Daunorubicin 112. Delamanid 113. Desferrioxamine 114. Dexamethasone 115. Dextran-40 116. Diazepam 117. Diclofenac 118. Dicyclomine 119. Diethylcarbamazine 120. Digoxin 121. Diltiazem 122. Dinoprostone 123. Diphtheria antitoxin 124. Dobutamine 125. Docetaxel Alphabetical List of Medicines in NLEM 2022 126. Dolutegravir 127. Domperidone 128. Donepezil 129. Dopamine 130. Doxorubicin 131. Doxycycline 132. DPT vaccine 133. DPT+ Hib+ Hep B vaccine 134. Efavirenz 135. Enalapril 136. Enoxaparin 137. Entecavir 138. Erythropoietin 139. Escitalopram 140. Esmolol 141. Ethambutol 142. Ethinylestradiol (A) + Levonorgestrel (B) 143. Ethionamide 144. Ethyl alcohol (Denatured) 145. Etoposide 146. Fentanyl 147. Ferrous Salts (A) + Folic Acid (B) 148. Ferrous salts 149. Filgrastim 150. Fluconazole Alphabetical List of Medicines in NLEM 2022 151. Fludrocortisone 152. Flunarizine 153. Fluorescein 154. Fluoxetine 155. Fluphenazine 156. Folic Acid 157. Framycetin 158. Fresh frozen plasma 159. Furosemide 160. Fusidic acid 161. Gadobenate dimeglumine 162. Gefitinib 163. Gemcitabine 164. Gentamicin 165. Glimepiride 166. Glucose 167. Glucose(A) + Sodium chloride (B) 168. Glutaraldehyde 169. Glycerin 170. Glyceryl trinitrate 171. Glycopyrrolate 172. Griseofulvin 173. Haemodialysis fluid 174. Haloperidol 175. Halothane Alphabetical List of Medicines in NLEM 2022 176. Heparin 177. Hepatitis B immunoglobulin 178. Hepatitis B vaccine 179. Homatropine 180. Hormone releasing IUD 181. Human chorionic gonadotropin 182. Human normal immunoglobulin 183. Hydrochlorothiazide 184. Hydrocortisone 185. Hydrogen Peroxide 186. Hydroxocobalamine 187. Hydroxychloroquine 188. Hydroxypropyl methylcellulose 189. Hydroxyurea 190. Hyoscine butylbromide 191. Ibuprofen 192. Ifosfamide 193. Imatinib 194. Insulin (Soluble) 195. Insulin Glargine 196. Insulin Intermediate Acting (NPH) 197. Insulin Premix Injection 30:70 (Regular : NPH) 198. Iohexol 199. Ipratropium 200. Irinotecan HCI Trihydrate 201. Iron sucrose Alphabetical List of Medicines in NLEM 2022 202. Isoflurane 203. Isoniazid 204. Isosorbide dinitrate 205. Ispaghula 206. Itraconazole 207. IUD containing Copper 208. Ivermectin 209. Japanese Encephalitis Vaccine 210. Ketamine 211. Labetalol 212. Lactulose 213. Lamivudine 214. L-Asparaginase 215. Latanoprost 216. Lenalidomide 217. Letrozole 218. Leuprolide acetate 219. Levetiracetam 220. Levodopa (A) + Carbidopa (B) 221. Levofloxacin 222. Levonorgestrel 223. Levothyroxine 224. Lignocaine 225. Lignocaine (A) + Adrenaline (B) 226. Linezolid Alphabetical List of Medicines in NLEM 2022 227. Lithium 228. Loperamide 229. Lopinavir (A) + Ritonavir (B) 230. Lorazepam 231. Magnesium sulphate 232. Mannitol 233. Measles vaccine 234. Mebendazole 235. Medroxyprogesterone acetate 236. Mefenamic acid 237. Mefloquine 238. Meglumine diatrizoate 239. Melphalan 240. Meropenem 241. Mesna 242. Metformin 243. Methotrexate 244. Methylergometrine 245. Methylprednisolone 246. Methylrosanilinium chloride (Gentian Violet) 247. Methylthioninium chloride (Methylene blue) 248. Metoclopramide 249. Metoprolol 250. Metronidazole 251. Midazolam 252. Mifepristone 253. Miltefosine Alphabetical List of Medicines in NLEM 2022 254. Misoprostol 255. Montelukast 256. Morphine 257. Moxifloxacin 258. Mupirocin 259. Mycophenolate mofetil 260. N-acetylcysteine 261. Naloxone 262. Natamycin 263. Neostigmine 264. Nevirapine 265. Nicotine replacement therapy (NRT) 266. Nifedipine 267. Nitrofurantoin 268. Nitrous oxide 269. Noradrenaline 270. Norethisterone 271. Nystatin 272. Omeprazole 273. Ondansetron 274. Oral poliomyelitis vaccine 275. Oral rehydration salts 276. Ormeloxifene (Centchroman) 277. Oxaliplatin 278. Oxygen Alphabetical List of Medicines in NLEM 2022 279. Oxytocin 280. Paclitaxel 281. Pantoprazole 282. Para- aminosalicylic acid 283. Paracetamol 284. Paromomycin 285. Peritoneal dialysis solution 286. Permethrin 287. Pheniramine 288. Phenobarbitone 289. Phenoxymethyl penicillin 290. Phenylephrine 291. Phenytoin 292. Phytomenadione(Vitamin K1) 293. Pilocarpine 294. Piperacillin (A) + Tazobactam (B)* 295. Platelet rich plasma/ Platelet concentrates 296. Podophyllin resin 297. Potassium chloride 298. Potassium permanganate 299. Povidone iodine 300. Pralidoxime chloride (2-PAM) 301. Praziquantel 302. Prednisolone 303. Primaquine 304. Procaine Benzylpenicillin Alphabetical List of Medicines in NLEM 2022 305. Proparacaine 306. Propofol 307. Propranolol 308. Protamine Sulphate 309. Pyrazinamide 310. Pyridoxine 311. Quinine 312. Rabies vaccine 313. Raltegravir 314. Ramipril 315. Red blood cells/ Packed RBCs 316. Ribavirin 317. Riboflavin 318. Rifampicin 319. Ringer lactate 320. Risperidone 321. Ritonavir 322. Rituximab 323. Rotavirus vaccine 324. Salbutamol 325. Salicylic acid 326. Sevoflurane 327. Silver sulphadiazine Alphabetical List of Medicines in NLEM 2022 328. Snake Venom Antiserum a. Soluble/ liquid polyvalent b. Lyophilized polyvalent 329. Sodium bicarbonate 330. Sodium chloride 331. Sodium nitrite 332. Sodium nitroprusside 333. Sodium thiosulphate 334. Sodium Valproate 335. Sofosbuvir 336. Somatostatin 337. Spironolactone 338. Streptokinase 339. Streptomycin 340. Succinylcholine 341. Sulfasalazine 342. Sumatriptan 343. Surfactant 344. Tacrolimus 345. Tamoxifen 346. Telmisartan 347. Temozolomide 348. Tenecteplase 349. Teneligliptin 350. Tenofovir (A) + Lamivudine (B) Alphabetical List of Medicines in NLEM 2022 351. Tenofovir (A) + Lamivudine (B) + Dolutegravir (C) 352. Tenofovir (A) + Lamivudine (B) + Efavirenz (C) 353. Tenofovir Alafenamide Fumarate (TAF) 354. Tenofovir Disproxil Fumarate (TDF) 355. Terbinafine 356. Tetanus toxoid 357. Thalidomide 358. Thiamine 359. Thiopentone 360. Timolol 361. Tiotropium 362. Tramadol 363. Tranexamic acid 364. Trastuzumab 365. Trihexyphenidyl 366. Tropicamide 367. Tuberculin, Purified Protein derivative 368. Valganciclovir 369. Vancomycin 370. Vecuronium 371. Verapamil 372. Vinblastine 373. Vincristine 374. Vitamin A Alphabetical List of Medicines in NLEM 2022 375. Warfarin 376. Water for Injection 377. Whole blood 378. Xylometazoline 379. Zidovudine 380. Zidovudine (A) + Lamivudine (B) 381. Zidovudine (A) + Lamivudine (B) + Nevirapine (C) 382. Zinc Sulphate 383. Zoledronic acid 384. Zolpidem Medicines Added Therapeutic category wise in NLEM 2022 Medicines Added Therapeutic category wise in NLEM 2022 Section 1 Medicines used in Anaesthesia NIL Section 2 Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders NIL Section 3 Antiallergics and medicines used in anaphylaxis NIL Section 4 Antidotes and Other Substances used in Management of Poisonings/Envenomation NIL Section 5 Medicines used in Neurological disorders NIL Section 6 Anti-infective medicines 6.1.2 -Antifilarial Medicine Level of Healthcare Dosage form(s) and strength(s) 1 6.1.5 Ivermectin P,S,T Tablet 6 mg Tablet 12 mg 6.2-Antibacterials 6.2.1 Beta-lactam Medicines 2 6.2.1.14 Meropenem T Powder for Injection 500 mg (as trihydrate) Powder for Injection 1000 mg (as trihydrate) 6.2.2 - Other antibacterials Medicine Level of Healthcare Dosage form(s) and strength(s) 3 6.2.2.2 Cefuroxime P,S,T Tablet 500 mg Syrup 125 mg/ 5 mL (p) Injection 1500 mg 4 6.2.2.11 Phenoxymethyl penicillin P,S,T Tablet 250 mg 5 6.2.2.12 Procaine Benzylpenicillin P,S,T Powder for injection 1000 mg (=1 million IU) 6.4-Antituberculosis medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 6 6.4.1 Amikacin S,T Injection 100 mg/mL Injection 250 mg/mL Injection 500 mg/mL 7 6.4.2 Bedaquiline T Tablet 100 mg 8 6.4.7 Delamanid T Tablet 50 mg 6.5-Antifungal medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 9 6.5.5 Itraconazole S,T Capsule 100 mg Capsule 200 mg Oral liquid 10 mg/mL 10 6.5.6 Mupirocin P,S,T Ointment 2% 11 6.5.8 Terbinafine P,S,T Cream 1% 6.6.2 - Anti-Cytomegalovirus (CMV) medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 12 6.6.2.1 Valganciclovir S, T Tablet 450 mg Powder for oral solution 50 mg/mL 6.7- Medicines used in the Management of HIV 13 6.7.1.3 Lamivudine S,T Tablet 100 mg Tablet 150 mg 14 6.7.1.5 Tenofovir (A) + Lamivudine (B) + Dolutegravir (C) P,S,T Tablet 300 mg (A) + 300 mg (B) + 50 mg (C) 6.7.3 - Integrase inhibitors Medicine Level of Healthcare Dosage form(s) and strength(s) 15 6.7.3.1 Dolutegravir S,T Tablet 50 mg 6.7.4-Protease inhibitors Medicine Level of Healthcare Dosage form(s) and strength(s) 16 6.7.4.3 Darunavir (A) + Ritonavir (B) S,T Tablet 600 mg (A) + Tablet 100 mg (B) 6.8 - Medicines for hepatitis B and hepatitis C Medicine Level of Healthcare Dosage form(s) and strength(s) 17 6.8.1 Daclatasvir S,T Tablet 60 mg Tablet 30 mg 18 6.8.5 Tenofovir Alafenamide Fumarate (TAF) S,T Tablet 25 mg Section 7 Antimigraine medicines (Now in Section 5 Medicines used in Neurological Disorders) NIL Section 8 Anti-cancer agents including Immunosuppressives and Medicines used in Palliative Care (Now in Section 7) 7.1- Antineoplastic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 19 7.1.6 Bendamustine Hydrochloride T Injection 25 mg Injection 100 mg/vial 20 7.1.26 Irinotecan HCI Trihydrate T Solution for injection 20 mg/ mL 21 7.1.28 Lenalidomide T Capsule 5 mg Capsule 25 mg 7.2-Hormones and anti-hormones used in cancer therapy Medicine Level of Healthcare Dosage form(s) and strength(s) 22 7.2.3 Leuprolide acetate T Powder for injection 3.75 mg Powder for injection 11.25 mg Powder for injection 22.5 mg Section 8 Medicines affecting Blood NIL Section 9 Antiparkinsonism medicines (Now in Section 5.3 Medicines used in Neurological Disorders) NIL Section 10 Medicines affecting Blood NIL Section 11 Blood products and Plasma substitutes NIL Section 12 Cardiovascular Medicines (Now in Section 10) 10.5- Antiplatelet and Antithrombotic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 23 10.5.3 Dabigatran S, T Tablet 110 mg Tablet 150 mg 24 10.5.7 Tenecteplase S,T Injection 30 mg/vial Injection 40 mg/vial Section 13 Dermatological medicines (Topical) NIL Section 14 Dermatological medicines (Topical) NIL Section 15 Diagnostic Agents NIL Section 16 Dialysis solutions NIL Section 17 Disinfectants and Antiseptics and NIL Section 18 Diuretics NIL Section 19 Ear, Nose and Throatmedicines NIL Section 20 Gastrointestinal medicines NIL Section 21 Hormones, other Endocrine Medicines and Contraceptives (Now in Section 18) 18.1-Adrenal Hormones and Synthetic substitutes Medicine Level of Healthcare Dosage form(s) and strength(s) 25 18.1.2 Fludrocortisone S,T Tablet 100 mcg 18.2 - Contraceptives 18.2.1 - Hormonal Contraceptives Medicine Level of Healthcare Dosage form(s) and strength(s) 26 18.2.3 Ormeloxifene P,S,T Tablet 30 mg (Centchroman) 18.3 Medicines used in diabetes mellitus 18.3.1 Insulins and other antidiabetic agents 27 18.3.1.4 Insulin Glargine P,S,T Injection 100 IU/mL 28 18.3.1.7 Teneligliptin P,S,T Tablet 20 mg Section 22 Immunologicals (Now in Section 19) For universal immunization Medicine Level of Healthcare Dosage form(s) and strength(s) 29 19.4.8 Rotavirus vaccine P, S, T As licensed Section 23 Muscle relaxants and cholinesterase inhibitors (Now in Section 1- Medicines used in Anaesthesia) (sub-section 1.4 - Muscle relaxants and cholinesterase inhibitors) NIL Section 24 Medicines for neonatal care NIL Section 25 Ophthalmological Medicines (Now in Section 21) 21.4-Miotics and Antiglaucoma Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 30 21.4.2 Latanoprost P,S,T Drops 0.005 % Section 26 Oxytocics and Antioxytocic NIL Section 27 Medicines used in treatment of Psychiatric Disorders (Now in Section 23) 23.5-Medicines for disorders due to psychoactive substance abuse Medicine Level of Healthcare Dosage form(s) and strength(s) 31 23.5.1 Buprenorphine P,S,T Tablet (Sub-lingual) 0.4 mg 32 23.5.2 Buprenorphine (A) + Naloxone (B) P,S,T Tablet (Sub-lingual) 0.4 mg (A) + 0.1 mg (B) Tablet (Sub-lingual) 2 mg (A) + 0.5 mg (B) 33 23.5.3 Nicotine (for nicotine replacement therapy) P,S,T Oral Dosage forms 2 mg Oral Dosage forms 4 mg Section 28 Medicines acting on the respiratory tract (Now in Section 24) 24.1-Antiasthmatic Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 34 24.1.8 Montelukast S,T Tablet 4 mg Tablet 5 mg (including chewable tablets) Tablet 10 mg Section 29 Solutions correcting Water, Electrolyte disturbances and Acid-base disturbances (Now in Section 25) NIL Section 30 Vitamins and minerals (Now in Section 26) NIL Alphabetical List of Medicines Added to NLEM 2022 Alphabetical List of Medicines Added to NLEM 2022 1. Amikacin 2. Bedaquiline 3. Bendamustine Hydrochloride 4. Buprenorphine 5. Buprenorphine (A) + Naloxone (B) 6. Cefuroxime 7. Dabigatran 8. Daclatasvir 9. Darunavir (A) + Ritonavir (B) 10. Delamanid 11. Dolutegravir 12. Fludrocortisone 13. Insulin Glargine 14. Irinotecan HCI Trihydrate 15. Itraconazole 16. Ivermectin 17. Lamivudine 18. Latanoprost Alphabetical List of Medicines Added to NLEM 2022 19. Lenalidomide 20. Leuprolide acetate 21. Meropenem 22. Montelukast 23. Mupirocin 24. Nicotine replacement therapy (NRT) 25. Ormeloxifene (Centchroman) 26. Phenoxymethyl penicillin 27. Procaine Benzyl penicillin 28. Rotavirus vaccine 29. Tenecteplase 30. Teneligliptin 31. Tenofovir (A) + Lamivudine (B) + Dolutegravir (C) 32. Tenofovir Alafenamide Fumarate (TAF) 33. Terbinafine 34. Valganciclovir Medicines Deleted from Therapeutic category wise NLEM 2015 Medicines Deleted from Therapeutic category wise NLEM 2015 Section 1 Anaesthetic Agents Medicine Level of Healthcare Dosage form(s) and strength(s) 1 1.2.4 Prilocaine (A) + Lignocaine (B) T Cream 2.5% (A) + 2.5% (B) Section 2-Analgesics, antipyretics, non-steroidal anti-inflammatory medicines, medicines used to treat Gout and disease Modifying agents used in Rheumatoid Disorders Medicine Level of Healthcare Dosage form(s) and strength(s) 2 2.4.3 Leflunomide S,T Tablet 10 mg Tablet 20 mg Section 3-Antiallergics and medicines used in anaphylaxis Medicine Level of Healthcare Dosage form(s) and strength(s) 3 3.3 Chlorpheniramine P,S,T Tablet 4 mg Oral liquid 2 mg/5 ml Section 4-Antidotes and Other substances used in poisoning treatment 4.2 Specific Medicine Level of Dosage form(s) and strength(s) Healthcare 4 4.2.4 Dimercaprol S,T Injection 50 mg/ml Section 5 Medicines used in Neurological Disorders NIL Section 6-Anti-infective medicines 6.2.4-Antituberculosis medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 5 6.2.4.1 Capreomycin P,S,T Powder for Injection 1 g 6 6.2.4.6 Kanamycin P,S,T Powder for Injection 500 mg Powder for Injection 750 mg Powder for Injection 1 g 7 6.2.4.12 Rifabutin S,T Capsule 150 mg 6.4.2-Anti Cytomegalovirus (CMV) medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 8 6.4.2.1 Ganciclovir S,T Capsule 250 mg Powder for Injection 500 mg 6.4.3-Medicines used in the management of HIV 6.4.3.1 -Nucleoside reverse transcriptase inhibitors Medicine Level of Healthcare Dosage form(s) and strength(s) 9 6.4.3.1.3 Lamivudine (A) + Nevirapine (B) + Stavudine (B) S,T Dispersible Tablet 30mg (A) + 50mg (B) + 6mg (C) Tablet 150mg (A) + 200mg (B) + 30mg (C) 10 6.4.3.1.5 Stavudine (A) + Lamivudine (B) S,T Dispersible Tablet 6 mg (A) + 30 mg (B) (p) Tablet 30 mg (A) + 150 mg (B) 6.4.4-Medicines for hepatitis B and hepatitis C Medicine Level of Healthcare Dosage form(s) and strength(s) 11 6.4.4.2 Pegylated interferon alfa 2a S,T Injection 180 mcg Pegylated interferon alfa 2b S,T Injection 80 mcg Injection 100 mcg Injection 120 mcg 6.5.1 Antiamoebic and antigiardiasis medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 12 6.5.1.1 Diloxanide furoate P,S,T Tablet 500 mg 6.5.4-Antipneumocystosis and antitoxoplasmosis medicines 13 6.5.4.2 Pentamidine S,T Powder for Injection 200 mg Section 7 Antimigraine medicines NIL Section 8 Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care NIL Medicine Level of Healthcare Dosage form(s) and strength(s) 14 8.1.30 Procarbazine T Capsule 50 mg Section 9 Antiparkinsonism medicines NIL Section 10 Medicines affecting blood NIL 10.3-Antihypertensive Medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 15 12.3.6 Methyldopa P,S,T Tablet 250 mg Tablet 500 mg Section 11 Blood products and Plasma substitutes NIL Section 12- Cardiovascular Medicines 12.3-Antihypertensive medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 16 12.3.2 Atenolol P,S,T Tablet 50 mg Tablet 100 mg 12.5-Antithrombotic medicine (Cardiovascular/ Cerebrovascular) Medicine Level of Healthcare Dosage form(s) and strength(s) 17 12.5.2 Alteplase T Powder for Injection 20 mg Powder for Injection 50 mg Section 13 Dermatological medicines (Topical) NIL Section 14 Dermatological medicines (Topical) 14.6 Miscellaneous Medicine Level of Healthcare Dosage form(s) and strength(s) 18 14.6.2 White Petrolatum P,S,T Jelly 100% Section 15 Diagnostic agents NIL Section 16 Dialysis solutions NIL Section 17 Antiseptics and Disinfectants 17.1- Antiseptics Medicine Level of Healthcare Dosage form(s) and strength(s) 19 17.1.1 Cetrimide P,S,T Solution 20 % (Concentrate for dilution) 17.2 Disinfectants 20 17.2.1 Bleaching powder P,S,T Containing not less than 30%w/w of available chlorine (as per I.P) Section 18 Diuretics NIL Section 19 Ear, Nose and Throatmedicines NIL Section 20 Gastrointestinal medicines 20.1 Antiulcer medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 21 20.1.4 Sucralfate S,T Oral liquid 1g 22 20.1.3 Ranitidine P,S,T Tablet 150 mg Oral liquid 75 mg/5 mL Injection 25 mg/mL Section 21 Hormones, other Endocrine Medicines and Contraceptives 21.2.1 Hormonal contraceptives Medicine Level of Healthcare Dosage form(s) and strength(s) 23 21.2.1.2 Ethinylestradiol (A) + Norethisterone (B) P,S,T Tablet 0.035 mg (A) +1 mg (B) 21.3 Estrogens 24 21.3.1 Ethinylestradiol P,S,T Tablet 0.01 mg Tablet 0.05 mg Section 22 Immunologicals NIL Section 23 Muscle relaxants and cholinesterase inhibitors NIL Section 24 Medicines for neonatal care NIL Section 25 Ophthalmological Medicines 25.1-Anti-infective medicines Medicine Level of Healthcare Dosage form(s) and strength(s) 25 25.1.3 Erythromycin P,S,T Ointment 0.5 % Section 26 Oxytocics and Antioxytocics NIL Section 27 Medicines in treatment of Psychiatric Disorders NIL Section 28 Medicines acting on the respiratory tract NIL Section 29 Solutions correcting water, electrolyte disturbances and acid-base disturbances NIL Section 30 Vitamins and minerals Medicine Level of Healthcare Dosage form(s) and strength(s) 26 30.5 Nicotinamide P,S,T Tablet 50 mg Alphabetical List of Medicines Deleted from NLEM 2015 Alphabetical List of Medicines Deleted from NLEM 2015 1. Alteplase 2. Atenolol 3. Bleaching Powder 4. Capreomycin 5. Cetrimide 6. Chlorpheniramine 7. Diloxanide furoate 8. Dimercaprol 9. Erythromycin 10. Ethinylestradiol 11. Ethinylestradiol(A) Norethisterone (B) 12. Ganciclovir 13. Kanamycin 14. Lamivudine (A) + Nevirapine (B) + Stavudine (C) 15. Leflunomide 16. Methyldopa 17. Nicotinamide 18. Pegylated interferon alfa 2a, Pegylated interferon alfa 2b 19. Pentamidine 20. Prilocaine (A) + Lignocaine (B) 21. Procarbazine 22. Ranitidine 23. Rifabutin 24. Stavudine (A) + Lamivudine (B) 25. Sucralfate 26. White Petrolatum 5-aminosalicylic acid, 61 5-Fluorouracil, 37 6-Mercaptopurine, 37 Abacavir, 28 Abacavir (A) + Lamivudine (B), 29 Acetazolamide, 72 Acetylsalicylic acid, 6, 15, 52 Actinomycin D, 37 Activated Charcoal, 11 Acyclovir, 28, 31, 71 Adenosine, 50 Adrenaline, 9 Albendazole, 18 Allopurinol, 8, 42 All-trans retinoic acid, 37 Alprostadil, 70 Amikacin, 24 Amiodarone, 50 Amitriptyline, 16, 42, 75 Amlodipine, 50 Amoxicillin, 19 Amoxicillin (A) + Clavulanic acid (B), 19 Amphotericin B, 26, 34 Ampicillin, 20 Anti-D immunoglobulin, 68 Anti-rabies immunoglobulin, 68 Anti-tetanus immunoglobulin, 68 Arsenic trioxide, 37 Artemether (A) + Lumefantrine (B), 35 Artesunate, 35 Artesunate (A) + Sulphadoxine - Pyrimethamine (B), 35 Ascorbic acid, 81 Atazanavir (A) + Ritonavir (B), 30 Atorvastatin, 53 Atracurium, 5 Atropine, 4, 11, 72 Azathioprine, 9, 41 Azithromycin, 21, 32 Baclofen, 5 Barium sulphate, 56 BCG vaccine, 69 Bedaquiline, 24 Bendamustine Hydrochloride, 37 Benzathine benzylpenicillin, 20 Benzoyl peroxide, 55 Benzylpenicillin, 20 Betamethasone, 74 Betamethasone (valerate), 54 Bicalutamide, 40 Bisacodyl, 61 Bleomycin, 37 Bortezomib, 37 Budesonide, 59, 78 Budesonide (A) +Formoterol (B), 79 Bupivacaine, 4 Buprenorphine, 78 Buprenorphine (A) + Naloxone (B), 78 Caffeine, 70 Calamine, 55 Calcium carbonate, 81 Calcium folinate, 37 Calcium gluconate, 11, 81 Capecitabine, 37 Carbamazepine, 13, 76 Carbimazole, 67 Carboplatin, 41 Carboxymethyl cellulose, 73 Cefadroxil, 20 Cefazolin, 20 Cefixime, 20 Cefotaxime, 20, 31 Ceftazidime, 21 Ceftriaxone, 21 Cefuroxime, 21 Cetirizine, 9 Chlorambucil, 38 Chlorhexidine, 57 Chloroquine, 36 Cholecalciferol, 81 Ciprofloxacin, 22, 59, 71 Cisplatin, 38 Clarithromycin, 22, 24 Clindamycin, 22, 31, 34, 36 Clobazam, 13 Clofazimine, 24, 25 Clomiphene citrate, 66 Clomipramine, 77 Clonazepam, 77 Clopidogrel, 53 INDEX Clotrimazole, 27, 32, 54, 59 Cloxacillin, 21 Clozapine, 74 Coagulation factor IX, 48 Coagulation factor VIII, 48 Coal tar (A) + Salicylic Acid (B), 55 Colchicine, 8 Condom, 65 Co-trimoxazole [Sulphamethoxazole (A) + Trimethoprim (B)], 22, 35 Cryoprecipitate, 48 Cyclophosphamide, 38 Cycloserine, 25 Cyclosporine, 41 Cytosine Arabinoside, 38 D- Penicillamine, 11 Dabigatran, 53 Dacarbazine, 38 Daclatasvir, 32 Dapsone, 24 Darunavir, 31 Darunavir (A) + Ritonavir (B), 31 Daunorubicin, 38 Delamanid, 25 Desferrioxamine, 11 Dexamethasone, 10, 42, 63, 82 Dextran-40, 48 Diazepam, 13, 43 Diclofenac, 7 Dicyclomine, 61 Diethylcarbamazine (DEC), 11 Digoxin, 50, 51 Diltiazem, 49 Dinoprostone, 73 Diphtheria antitoxin, 68 Dobutamine, 52 Docetaxel, 38 Dolutegravir, 30 Domperidone, 60 Donepezil, 17 Dopamine, 52 Doxorubicin, 38 Doxycycline, 23, 36 DPT vaccine, 69 DPT+ Hib+ Hep B vaccine, 69 Efavirenz, 30 Enalapril, 51 Enoxaparin, 46, 53, 82 Entecavir, 32 Erythropoietin, 45 Escitalopram, 76 Esmolol, 50 Ethambutol, 25 Ethinylestradiol (A)+ Levonorgestrel (B), 64 Ethionamide, 25 Ethyl alcohol (Denatured), 57 Etoposide, 38 Fentanyl, 7 Ferrous Salt (A)+ Folic acid (B), 45 Ferrous salts, 45 Filgrastim, 43 Fluconazole, 27 Fludrocortisone, 63 Flunarizine, 17 Fluorescein, 56 Fluoxetine, 43, 76, 77 Fluphenazine, 74 Folic Acid, 46 Framycetin, 54 Fresh Frozen Plasma, 47 Furosemide, 58 Fusidic acid, 54 Gadobenate dimeglumine, 56 Gefitinib, 38 Gemcitabine, 39 Gentamicin, 23 Glimepiride, 65 Glucose(A) + Sodium chloride (B), 80 Glucose, 66, 80 Glutaraldehyde, 58 Glycerin (as mentioned in IP), 55 Glyceryl trinitrate, 49 Glycopyrrolate, 5 Griseofulvin, 27 Haemodialysis fluid, 57 Haloperidol, 75 Halothane, 3 Heparin, 46, 53 Hepatitis B immunoglobulin, 68 Hepatitis B vaccine, 69 Homatropine, 73 Hormone Releasing IUD, 65 Human chorionic gonadotropin, 66 Human normal immunoglobulin, 58 Hydrochlorothiazide, 51, 58 Hydrocortisone, 10, 63, 79 Hydrogen peroxide, 57 Hydroxocobalamin, 46 Hydroxychloroquine, 9 Hydroxypropyl methylcellulose, 73 Hydroxyurea, 39, 46 Hyoscine butyl bromide, 61 Ibuprofen, 7, 16 Ifosfamide, 39 Imatinib, 39 Insulin (Soluble), 65 Insulin Glargine, 66 Insulin Intermediate Acting (NPH), 65 Insulin Premix, 66 Iohexol, 56 Ipratropium, 79 Irinotecan HCI Trihydrate, 39 Iron sucrose, 46 Isoflurane, 3 Isoniazid, 25 Isosorbide dinitrate, 49 Isosorbide-5- mononitrate, 53 Ispaghula, 61 Itraconazole, 27 IUD containing Copper, 65 Ivermectin, 19 Japanese Encephalitis vaccine, 69 Ketamine, 3 Labetalol, 51 Lactulose, 43, 62 Lamivudine, 29 L-Asparaginase, 39 Latanoprost, 72 Lenalidomide, 39 Letrozole, 40 Leuprolide acetate, 41 Levetiracetam, 13 Levodopa (A) + Carbidopa (B), 17 Levofloxacin, 25 Levonorgestrel, 64 Levothyroxine, 67 Lignocaine, 4, 50 Lignocaine (A) + Adrenaline (B), 4 Linezolid, 25 Lithium, 76 Loperamide, 43 Lopinavir (A) + Ritonavir (B), 31 Lorazepam, 13 Magnesium sulphate, 14 Mannitol, 58 Measles vaccine, 70 Mebendazole, 18 Medroxyprogesterone acetate, 67 Mefenamic acid, 7 Mefloquine, 36 Meglumine diatrizoate, 56 Melphalan, 39 Meropenem, Mesna, 44 Metformin, 66 Methotrexate, 9, 39 Methylergometrine, 73 Methylprednisolone, 63, 83 Methylrosanilinium chloride, 57 Methylthioninium chloride, 11 Metoclopramide, 44, 60 Metoprolol, 49 Metronidazole, 25, 33 Midazolam, 5, 14, 44 Mifepristone, 74 Miltefosine, 34 Misoprostol, 74 Montelukast, 79 Morphine, 5, 8, 44 Moxifloxacin, 25 Mupirocin, 27 Mycophenolate mofetil, 42 N-acetylcysteine, 12 Naloxone, 12 Natamycin, 71 Neostigmine, 6, 12 Nevirapine, 30 Nicotine (for nicotine replacement therapy), 78 Nifedipine, 74 Nitrofurantoin, 23 Nitrous oxide, 3 Noradrenaline, 52 Norethisterone, 67 Nystatin, 27 Omeprazole, 60 Ondansetron, 44, 60 Oral poliomyelitis vaccine, 70 Oral rehydration salts, 62, 80 Ormeloxifene, 64 Oxaliplatin, 40 Oxygen, 3, 83 Oxytocin, 74 Paclitaxel, 40 Pantoprazole, 60 Para- aminosalicylic acid, 26 Paracetamol, 7, 16, 83 Paromomycin, 34 Peritoneal dialysis solution, 57 Permethrin, 55 Pheniramine, 10 Phenobarbitone, 14 Phenoxymethyl penicillin, 23 Phenylephrine, 73 Phenytoin, 14 Phytomenadione, 46 Pilocarpine, 72 Piperacillin (A) + Tazobactam (B), 21 Platelet rich plasma/ Platelet concentrates, 47 Podophyllin resin, 55 Potassium chloride, 80 Potassium permanganate, 58 Povidone iodine, 57, 71 Pralidoxime chloride (2-PAM), 12 Praziquantel, 19 Prednisolone, 10, 41, 64, 71 Primaquine, 36 Procaine Benzylpenicillin, 23 Proparacaine, 56, 72 Propofol, 3 Propranolol, 17 Protamine Sulphate, 46 Pyrazinamide, 26 Pyridoxine, 82 Quinine, 36 Rabies vaccine, 70 Raltegravir, 30 Ramipril, 51 Red blood cells, 47 Ribavirin, 33 Riboflavin, 82 Rifampicin, 24, 26 Ringer lactate, 81 Risperidone, 75 Ritonavir, 31 Rituximab, 40 Rotavirus vaccine, 70 Salbutamol, 79 Salicylic acid, 55 Sevoflurane, 3 Silver sulphadiazine Snake Venom Antiserum, 12, 68 Sodium bicarbonate, 81 Sodium chloride, 81 Sodium nitrite, 12 Sodium Nitroprusside, 51 Sodium thiosulphate, 12 Sodium Valproate, 15, 76 Sofosbuvir, 33 Somatostatin, 62 Spironolactone, 52, 58 Streptokinase, 53 Streptomycin, 26 Succinylcholine, 6 Sulfasalazine, 9 Sumatriptan, 16 Surfactant, 70 Tacrolimus, 42 Tamoxifen, 41 Telmisartan, 51 Temozolomide, 40 Tenecteplase, 53 Teneligliptin, 66 Tenofovir Disoproxil fumarate (A) + Lamivudine (B), 29 Tenofovir Disoproxil fumarate (A) + Lamivudine (B) + Dolutegravir (C), 29 Tenofovir Disoproxil fumarate (A) + Lamivudine (B) + Efavirenz (C), 29 Tenofovir Alafenamide Fumarate (TAF), 33 Tenofovir Disproxil Fumarate (TDF), 29, 33 Terbinafine, 27 Tetanus toxoid, 70 Thalidomide, 40 Thiamine, 82 Thiopentone, 3 Timolol, 72 Tiotropium, 80 Tramadol, 8, 45 Tranexamic acid, 46 Trastuzumab, 40 Trihexyphenidyl, 17 Tropicamide, 56, 73 Tuberculin Purified Protein derivative, 68 Valganciclovir, 28, 32 Vancomycin, 23 Vecuronium, 6 Verapamil, 50 Vinblastine, 40 Vincristine, 40 Vitamin A, 82 Warfarin, 47 Water for Injection, 81 Whole blood, 47 Xylometazoline, 59 Zidovudine, 29 Zidovudine (A) + Lamivudine (B), 29 Zidovudine (A) + Lamivudine (B) + Nevirapine (C),30 Zinc Sulphate, 62 Zoledronic acid, 45 Zolpidem, 77